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ABSTRACT  During embryonic development, cells of metazoan embryos need to communicate in 
order to construct the correct bodyplan. To do so, they use several signals that usually act through 
interactions between ligands and receptors. Interestingly, only a few pathways are known to be 
fundamental during animal development, and they are usually found in all the major metazoan 
clades, raising the following question: how have evolution of the actors and of the functions of 
these pathways participated in the appearance of the current diversity of animal morphologies?  The 
chordate lineage comprises vertebrates, their sister group the urochordates, and the cephalochor-
dates (i.e. amphioxus). Urochordates are quite derived relative to the chordate ancestor, whereas 
cephalochordates and vertebrates share many morphological traits. Thus, comparing embryonic 
development between vertebrates and cephalochordates should give us some insight into the an-
cestral characters present in chordates and into the morphological evolution in this clade. However, 
while much is known about the function of different signalling pathways in vertebrates, data are 
still scarce in the literature for cephalochordates. In this review, we summarize the current state of 
the field concerning the expression of actors and the function of the major cell-cell communication 
pathways, including Hedgehog (Hh), Notch, Nuclear Receptor (NR), Receptor Tyrosine Kinase (RTK), 
Transforming Growth Factor-b (TGF-b) and Wingless/Int (Wnt), in amphioxus. 
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Introduction
Vertebrates belong to the chordate group together with the 
urochordates, their sister group, and the cephalochordates (i.e. 
amphioxus). Although urochordates are more closely related to 
vertebrates, they show derived features making difficult the inference 
of ancestral characters by comparing their traits with those of the 
other clades (Delsuc et al., 2006). On the other hand, amphioxus 
seem to have retained many ancestral chordate characters at both 
developmental and genomic levels, making these small marine 
animals a good model for chordate evo-devo studies (Bertrand and 
Escriva, 2011). Most cephalochordates live in the sand in shallow 
waters and are filter feeders. They are gonochoric, and reproduc-
tion occurs through external fertilization in the sea water column 
after males and females have released their gametes at sunset 
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(Bertrand and Escriva, 2011). The transparent zygote divides to 
form a morula, and then a blastula consisting of a single cell layer 
surrounding a cavity, the blastocoel (Conklin, 1932, Hatschek, 1893, 
Holland and Holland, 2007, Kowalevsky, 1867). The vegetal region 
flattens and forms the vegetal plate, which will invaginate to form 
a gastrula with two germ layers. The external layer, the ectoderm, 
will develop to form both the epidermis on the ventral side, and 
the neural plate in the dorsal region (Fig. 1). The mesendoderm 
is the internal layer. Its axial dorsal region is fated to become the 
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notochord, whereas the dorsal paraxial mesendoderm gives rise 
to the somites. Finally, the ventral mesendoderm will form the 
embryonic gut. At the end of gastrulation, the epidermis that has 
detached from the neural plate covers the whole embryo. During 
neurulation, the neural plate curves to form the neural tube, which 
is enlarged in the most anterior region, forming the so-called cere-
bral vesicle (Fig. 2). The somites start to form by enterocoely from 
the dorsal paraxial mesendoderm while the embryo elongates. 
In the late neurula stage embryo, several regions of the anterior 
endoderm begin to form different structures. Two diverticula are 
established in the most anterior region, the Hatschek’s left and 
right diverticulum, which will later develop into the pre-oral pit 
and the rostral coelom, respectively. On the right side, the future 
club-shaped gland and the region where the first gill slit will open 
can be detected, whereas the endostyle starts to develop from the 
ventral anterior endoderm. Finally, at the larval stage, the forma-
tion of these structures is achieved and the mouth opens on the 
left side (Fig. 2).
Many questions remain as to how cell-cell communication medi-
ates the processes taking place in these different developmental 
stages. In metazoans, few intercellular signals are known, and 
deciphering their specific functions in each lineage is crucial for 
our understanding of morphological evolution in animals. In this 
review, we will therefore briefly present the mode of action for 
the main signalling pathways (Hedgehog (Hh), Notch, Nuclear 
Receptor (NR), Receptor Tyrosine Kinase (RTK), Transforming 
Growth Factor-b (TGF-b), Wingless/Int (Wnt) pathways), as well as 
describe the embryonic expression of known actors in amphioxus. 
We will then detail available information on the embryonic function 
of each signal. Table 1 summarizes the bibliography concerning 
gene expression patterns, whereas Table 2 presents the main 
results obtained using pharmacological treatments to modulate 
these different pathways.
Hedgehog pathway
How does it work?
The role of the Hedgehog (Hh) signal during embryogenesis 
was first discovered in Drosophila. The name was derived from 
the phenotype of null mutants for Hh, which presented hair-bristles 
resembling the spines of the hedgehog (Nusslein-Volhard and 
Wieschaus, 1980). This signalling pathway is very complex and 
requires the participation of many actors in addition to the ligands 
and receptors. The Hedgehog ligand proteins contain two regions. 
The N-terminal region is the active peptide whereas the C-terminal 
region, which shows some similarity with inteins, possesses auto-
catalytic activity. After autocleavage of Hh, the N-terminal peptide 
is linked to a cholesterol molecule and to a palmitic acid and is 
recruited at the plasma membrane. From there it can be released 
in different ways into the extracellular space in order to spread 
Fig. 1. Early embryonic development in amphioxus. Three early developmental stages are presented, 
from gastrula to neurula. For each, two pictures of the same fixed embryo are shown together with 
small schemes indicating the different presumptive, or already formed, territories/structures. Scale 
bar, 50 mm.
through tissues (Briscoe and Therond, 
2013, Lee et al., 2016) (Fig. 3). The first 
identified receptor of Hh is a 12-pass 
transmembrane protein called Patched 
(Ptc), which acts as a constitutive repressor 
of the pathway (Hooper and Scott, 1989, 
Nakano et al., 1989). In the absence of 
Hh, Ptc represses Smoothened (Smo), 
a GPCR family protein, resulting in the 
proteolysis of the zinc-finger domain tran-
scription factor Gli (or Cubitus interruptus 
(Ci) in Drosophila), which is processed to 
its repressor form (Fig. 3). Following Hh 
binding to Ptc, Smo is activated and Gli 
translocates into the nucleus in its active 
form, leading to the transcription of target 
genes (Briscoe and Therond, 2013, Lee 
et al., 2016) (Fig. 3).
Receptors and ligands in amphioxus
Amphioxus possesses a unique Hh 
gene, orthologous to vertebrate Sonic, 
Indian and Desert Hedgehog (Shimeld, 
1999). Its expression pattern has been 
described in three amphioxus species, 
Branchiostoma floridae, B. belcheri and 
B. lanceolatum (Shimeld, 1999, Shimeld 
et al., 2007, Somorjai et al., 2008, Zhang 
et al., 2002). Hh transcripts are first 
detected in the dorsal mesendoderm at 
the early gastrula stage (Somorjai et al., 
2008, Zhang et al., 2002). As gastrulation 
proceeds, expression is observed in the 
presumptive notochord and floor plate 
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TABLE 1
AMPHIOXUS ACTORS OF THE DIFFERENT SIGNALLING PATHWAYS CITED IN THIS REVIEW 
AND REFERENCES OF ARTICLES IN WHICH THEIR EXPRESSION PATTERN HAS BEEN DESCRIBED
Pathways Actors Genes in amphioxus Orthologs in vertebrates (mammal/teleost common ancestor) Amphioxus developmental expression pattern 
Hedgehog     
 Receptors Patched (Ptc) Ptc1, Ptc2 (Lin et al., 2009) 
  Smoothened (Smo) Smo (Lin et al., 2009) 
 Ligand Hedgehog (Hh) Sonic Hedgehog, Indian Hedgehog, Desert Hedgehog (Shimeld, 1999, Somorjai et al., 2008, Zhang et 
al., 2002) 
 Others Gli Gli1, Gli2, Gli3 (Shimeld et al., 2007) 
  Sufu Sufu (Lin et al., 2009) 
NR     
 Receptor family NR0 NR0B DAX1, SHP  
 Receptor family NR1 TR TRα, TRβ (Paris et al., 2008) 
  RAR RARα, RARβ, RARγ (Escriva et al., 2002) 
  PPAR PPARα, PPARβ, PPARγ  
  REV-ERB REV-ERBα, REV-ERBβ, REV-ERBγ  
  ROR RORα, RORβ, RORγ  
  NR1H1-10 LXRα, LXRβ, FXRα, FXRβ  
  NR1I/J/K VDR, PXR, CAR  
 Receptor family NR2 HNF4 HNF4α, HNF4β, HNF4γ  
  RXR RXRα, RXRβ, RXRγ (Escriva et al., 2002) 
  TR2/4 TR2, TR4 (Escriva et al., 2002) 
  TLX TLX  
  PNR PNR  
  NR2E   
  COUP-TF COUP-TFα, COUP-TFβ, COUP-TFγ, EAR2 (Langlois et al., 2000) 
 Receptor family NR3 ER ERα, ERβ (Bridgham et al., 2008) 
  ERR ERRα, ERRβ, ERRδ, ERRγ (Bardet et al., 2005) 
  SR AR, GR, MR, PR (Bridgham et al., 2008) 
 Receptor family NR4 NR4A NGFI-B, NURR1, NOR1 (Candiani et al., 2009) 
 Receptor family NR5A NR5A SF1, LRH1  
 Receptor family NR6 GCNF GCNF  
 Others NRa   
  NRb   
  NRc   
Notch     
 Receptor Notch Notch1, Notch2, Notch3, (Notch4?) (Holland et al., 2001, Somorjai et al., 2008) 
 Ligands Delta DLK1, DLK2, DLL3 (Rasmussen et al., 2007) 
  JaggedA JAG1, JAG2  
  JaggedB JAG1, JAG2  
 Others Fringe Lunatic Fringe, Manic Fringe, Radical Fringe  (Mazet and Shimeld, 2003) 
RTK     
EPH Receptors EPH1 EPHA1-10, EPHB1-6 (Bosne, 2010) 
  EPH2 EPHA1-10, EPHB1-6 (Bosne, 2010) 
 Ligands Efn1 EFNA1-5, EFNB1-3 (Bosne, 2010) 
  Efn2 EFNA1-5, EFNB1-3 (Bosne, 2010) 
  Efn3 EFNA1-5, EFNB1-3  
FGFR Receptor FGFR FGFR1, FGFR2, FGFR3, FGFR4 (Bertrand et al., 2011) 
 Ligands FGF1/2 FGF1, FGF2 (Bertrand et al., 2011) 
  FGF8/17/18 FGF8, FGF17, FGF18, FGF24 (Bertrand et al., 2011; Meulemans and Bronner-
Fraser, 2007) 
  FGF9/16/20 FGF9, FGF16, FGF20 (Bertrand et al., 2011) 
  FGFA (FGF3, FGF7, FGF10, FGF22?) (Bertrand et al., 2011) 
  FGFB (FGF4, FGF5, FGF6?) (Bertrand et al., 2011) 
  FGFC (FGF19, FGF21, FGF23?) (Bertrand et al., 2011) 
  FGFD  (Bertrand et al., 2011) 
  FGFE  (Bertrand et al., 2011) 
INSR Receptor INSR INSR, INSRR, IGF1R (Pashmforoush et al., 1996) 
 Ligands Ilp Insulin, IGF1, IGF2 (Guo et al., 2009, Holland et al., 1997, Lecroisey 
et al., 2015) 
  Ilp2 Insulin, IGF1, IGF2  
PD/VEGFR Receptor PD/VEGFR PDGFRA, PDGFRB, FLT3, CSF1R, KIT, VEGFR1, VEGFR2, 
VEGFR3 
(Pascual-Anaya et al., 2013) 
TRK Receptor Trk NTRK1, NTRK2, NTRK3 (Benito-Gutierrez et al., 2005) 
 Ligand NT NGF, BDNF, NT-3, NT-4  
all RTKs Others AKT AKT1, AKT2, AKT3 (Bertrand et al., 2009) 
  PDK PDK (Bertrand et al., 2009) 
  PLCγ PLCγ1, PLCγ2 (Bertrand et al., 2009) 
  PKCα/β/γ PKCα, PKCβ, PKCδ (Bertrand et al., 2009) 
  RAF RAF1, ARAF, BRAF (Bertrand et al., 2009) 
  H/K/NRASa HRAS, NRAS, KRAS (Bertrand et al., 2009) 
TGF-β     
 Receptors type I Alk1/2 Alk1, Alk2  
  Alk3/6 Alk3, Alk6  
  Alk4/5/7 Alk4, Alk5, Alk7  
 Receptors type II TGF-βRII TGF-βRII  
  ActRII ActRII, ActRIIB  
  BMPRII BMPRII, AMHR2  
 Ligands BMP family ADMP ADMP (Kozmikova et al., 2013, Yu et al., 2007) 
  BMP2/4 BMP2, BMP4 (Kozmikova et al., 2013, Panopoulou et al., 1998, 
Yu et al., 2007) 
  BMP3/3b BMP3, GDF10 (Sun et al., 2010) 
  BMP5/8 BMP5, BMP6, BMP7, BMP8 (Kozmikova et al., 2013, Yu et al., 2007) 
  BMP9/10 BMP9, BMP10  
  GDF5/6/7 GDF5, GDF6, GDF7  
 Ligands Activin/Inhibin 1 (Inhibinβ-A, Inhibinβ-B, Inhibinβ-C, Inhibinβ-E ?)  
 TGFβ/Nodal/Activin family Activin/Inhibin 2 (Inhibinβ-A, Inhibinβ-B, Inhibinβ-C, Inhibinβ-E?)  
  Lefty Lefty1, Lefty2 (Morov et al., 2016, Onai et al., 2010, Yu et al., 
2007) 
  Myostatin Myostatin, GDF11  
  Nodal Nodal (Morov et al., 2016, Onai et al., 2010, Yu et al., 
2002, Yu et al., 2007) 
  TGF-β TGF-β TGF-β TGF-β  
  Vg1 GDF1 (Onai et al., 2010) 
 Others BAMBI BAMBI (Yu et al., 2007) 
  Chordin Chordin (Somorjai et al., 2008, Yu et al., 2007) 
  Cerberus Cerberus, DAND5 (Le Petillon et al., 2013, Onai et al., 2010) 
  Gremlin Gremlin1, Gremlin2 (Le Petillon et al., 2013) 
  NBL1 NBL1 (Le Petillon et al., 2013) 
  Tolloid BMP1, Tolloid like 1, Tolloid like 2 (Yu et al., 2007) 
  Tsg Tsg (Yu et al., 2007) 
Wnt     
 Receptors Frizzled 1/2/7 Fzd1, Fzd2 (Qian et al., 2013) 
  Frizzled 4 Fzd4 (Qian et al., 2013) 
  Frizzled 5/8 Fzd5, Fzd8 (Qian et al., 2013) 
  Frizzled 9/10 Fzd9, Fzd10 (Qian et al., 2013) 
 Antagonists sFRP1/2/5 SFRP1, SFRP2/sizzled, SFRP3/FrzB, sFRP5 (Kong et al., 2012, Yu et al., 2007)* 
  sFRP3/4 sFRP4 (Yu et al., 2007) 
  Dkk1/2/4 Dkk1 Dkk2, Dkk4 (Yu et al., 2007, Zhang and Mao, 2010) 
  Dkk3 Dkk3 (Yu et al., 2007, Zhang and Mao, 2010) 
 Co-Receptors LRP5/6 LRP5, LRP6 (Wang et al.) 
  Kremen1, Kremen2, 
Kremen3, Kremen4 
Kremen1, Kremen2 (Zhang and Mao, 2010) 
 Ligands Wnt1 Wnt1 (Holland et al., 2000) 
  Wnt2 Wnt2, Wnt2b/Wnt13 (Somorjai et al., in prep) 
  Wnt3 Wnt3, Wnt3a (Albuixech-Crespo et al., 2017, Schubert et al., 
2001, Somorjai et al., 2008, Yu et al., 2007)  
  Wnt4 Wnt4 (Schubert et al., 2000b) 
  Wnt5 Wnt5a, Wnt5b (Albuixech-Crespo et al., 2017, Schubert et al., 
2001, Somorjai et al., 2008, Somorjai et al., 2012) 
  Wnt6 Wnt6 (Schubert et al., 2001, Somorjai et al., 2008) 
  Wnt7 Wnt7a, Wnt7b (Albuixech-Crespo et al., 2017, Schubert et al., 
2000b, Somorjai et al., 2008)  
  Wnt8 Wnt8a, Wnt8b (Albuixech-Crespo et al., 2017, Morov et al., 2016, 
Schubert et al., 2000c, Yu et al., 2007) 
  Wnt9 Wnt9a, Wnt9b (Somorjai et al., in prep) 
  Wnt10 Wnt10a, Wnt10b (Somorjai et al., in prep) 
  Wnt11 Wnt11 (Schubert et al., 2000a, Yu et al., 2007) 
  Wnt16 Wnt16 (Somorjai et al., in prep) 
 Others Dsh Dvl1, Dvl2, Dvl3 (Wang et al., 2016) 
  Axin Axin1, Axin2 (Beaster-Jones et al., 2008, Wang et al., 2016) 
  GSK3β GSK3β (Wang et al., 2016) 
  β-catenin β-catenin, Plakoglobin  
  TCF TCF1, TCF3, TCF4, LEF1 (Lin et al., 2006) 
  CK1α CK1α (Wang et al., 2016) 
  CK1δ CK1δ (Wang et al., 2016) 
  Groucho Groucho (Wang et al., 2016) 
  APC APC (Wang et al., 2016) 
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and in two endodermal regions adjacent to the paraxial mesoderm 
(Shimeld, 1999, Somorjai et al., 2008). In neurula stage embryos 
and in larvae, Hh is expressed in the notochord, the tailbud, the 
endostyle and the pre-oral pit (Shimeld, 1999, Shimeld et al., 2007, 
Somorjai et al., 2008, Zhang et al., 2002), as well as transiently in 
some ventral neural tube cells (Shimeld, 1999). The expression 
of both Ptc, orthologous to Ptc1 and Ptc2 in vertebrates, and Smo 
was analyzed in B. belcheri (Lin et al., 2009). The Ptc transcripts 
are first detected in the dorsal region of gastrula stage embryos. 
In neurulae, Ptc is expressed in newly formed somites and in the 
anterior endoderm (Lin et al., 2009). As the embryo elongates, 
expression is also detected in the notochord, the presumptive gill 
slit and the pre-oral pit. Finally, at the larval stage, Ptc is expressed 
in the cerebral vesicle, the somites, the gill slits, the pre-oral pit, the 
club-shaped gland and in the gut and pharynx epithelium (Lin et al., 
2009). Smo has a similar expression pattern. It is first expressed 
later than Ptc in the newly formed somites and anterior endoderm 
in early neurula stage embryos (Lin et al., 2009). Expression is 
observed at later stages in the somites, the gut and the anterior 
notochord (Lin et al., 2009).
Other actors
The expression of two other major players of the Hh pathway 
has been described in amphioxus. A single Gli gene, orthologous to 
Gli1, 2 and 3 in vertebrates, was found in the amphioxus genome 
(Shimeld et al., 2007). This gene produces at least two splice vari-
ants and the presence of transcripts was first analyzed by using 
a probe able to recognize both (Shimeld et al., 2007). Gli expres-
sion is first detected in the dorsal ectoderm and mesendoderm of 
late gastrula embryos. In neurulae, Gli is expressed in the lateral 
neural plate and in the paraxial mesoderm, in cells alongside the 
Hh expressing regions. Expression then fades in these territories 
and is observed in the cerebral vesicle, in the Hatschek’s left 
diverticulum and in the forming gill slits. In the larva, labelling is 
observed in the cerebral vesicle, the pre-oral pit, the club-shaped 
gland as well as in the gill slits. Using a probe only recognizing the 
Pathways Actors Genes in amphioxus Orthologs in vertebrates (mammal/teleost common ancestor) Amphioxus developmental expression pattern 
Hedgehog     
 Receptors Patched (Ptc) Ptc1, Ptc2 (Lin et al., 2009) 
  Smoothened (Smo) Smo (Lin et al., 2009) 
 Ligand Hedgehog (Hh) Sonic Hedgehog, Indian Hedgehog, Desert Hedgehog (Shimeld, 1999, Somorjai et al., 2008, Zhang et 
al., 2002) 
 Others Gli Gli1, Gli2, Gli3 (Shimeld et al., 2007) 
  Sufu Sufu (Lin et al., 2009) 
NR     
 Receptor family NR0 NR0B DAX1, SHP  
 Receptor family NR1 TR TRα, TRβ (Paris et al., 2008) 
  RAR RARα, RARβ, RARγ (Escriva et al., 2002) 
  PPAR PPARα, PPARβ, PPARγ  
  REV-ERB REV-ERBα, REV-ERBβ, REV-ERBγ  
  ROR RORα, RORβ, RORγ  
  NR1H1-10 LXRα, LXRβ, FXRα, FXRβ  
  NR1I/J/K VDR, PXR, CAR  
 Receptor family NR2 HNF4 HNF4α, HNF4β, HNF4γ  
  RXR RXRα, RXRβ, RXRγ (Escriva et al., 2002) 
  TR2/4 TR2, TR4 (Escriva et al., 2002) 
  TLX TLX  
  PNR PNR  
  NR2E   
  COUP-TF COUP-TFα, COUP-TFβ, COUP-TFγ, EAR2 (Langlois et al., 2000) 
 Receptor family NR3 ER ERα, ERβ (Bridgham et al., 2008) 
  ERR ERRα, ERRβ, ERRδ, ERRγ (Bardet et al., 2005) 
  SR AR, GR, MR, PR (Bridgham et al., 2008) 
 Receptor family NR4 NR4A NGFI-B, NURR1, NOR1 (Candiani et al., 2009) 
 Receptor family NR5A NR5A SF1, LRH1  
 Receptor family NR6 GCNF GCNF  
 Others NRa   
  NRb   
  NRc   
Notch     
 Receptor Notch Notch1, Notch2, Notch3, (Notch4?) (Holland et al., 2001, Somorjai et al., 2008) 
 Ligands Delta DLK1, DLK2, DLL3 (Rasmussen et al., 2007) 
  JaggedA JAG1, JAG2  
  JaggedB JAG1, JAG2  
 Others Fringe Lunatic Fringe, Manic Fringe, Radical Fringe  (Mazet and Shimeld, 2003) 
RTK     
EPH Receptors EPH1 EPHA1-10, EPHB1-6 (Bosne, 2010) 
  EPH2 EPHA1-10, EPHB1-6 (Bosne, 2010) 
 Ligands Efn1 EFNA1-5, EFNB1-3 (Bosne, 2010) 
  Efn2 EFNA1-5, EFNB1-3 (Bosne, 2010) 
  Efn3 EFNA1-5, EFNB1-3  
FGFR Receptor FGFR FGFR1, FGFR2, FGFR3, FGFR4 (Bertrand et al., 2011) 
 Ligands FGF1/2 FGF1, FGF2 (Bertrand et al., 2011) 
  FGF /17/18 FGF8, FGF17, FGF18, FGF24 (Bertrand et al., 2011; Meulemans and Bronner-
Fraser, 2007) 
  FGF9/16/20 FGF9, FGF16, FGF20 (Bertrand et al., 2011) 
  FGFA (FGF3, FGF7, FGF10, FGF22?) (Bertrand et al., 2011) 
  FGFB (FGF4, FGF5, FGF6?) (Bertrand et al., 2011) 
  FGFC (FGF19, FGF21, FGF23?) (Bertrand et al., 2011) 
  FGFD  (Bertrand et al., 2011) 
  FGFE  (Bertrand et al., 2011) 
INSR Receptor INSR INSR, INSRR, IGF1R (Pashmforoush et al., 1996) 
 Ligands Ilp Insulin, IGF1, IGF2 (Guo et al., 2009, Holland et al., 1997, Lecroisey 
et al., 2015) 
  Ilp2 Insulin, IGF1, IGF2  
PD/VEGFR Receptor PD/VEGFR PDGFRA, PDGFRB, FLT3, CSF1R, KIT, VEGFR1, VEGFR2, 
VEGFR3 
(Pascual-Anaya et al., 2013) 
TRK Receptor Trk NTRK1, NTRK2, NTRK3 (Benito-Guti rrez et al., 2005) 
 Ligand NT NGF, BDNF, NT-3, NT-4  
all RTKs Others AKT AKT1, AKT2, AKT3 (Bertrand et al., 2009) 
  PDK PDK (Bertrand et al., 2009) 
  PLCγ PLCγ1, PLCγ2 (Bertrand et al., 2009) 
  PKCα/β/γ PKCα, PKCβ, PKCδ (Bertrand et al., 2009) 
  RAF RAF1, ARAF, BRAF (Bertrand et al., 2009) 
  H/K/NRASa HRAS, NRAS, KRAS (Bertrand et al., 2009) 
TGF-β     
 Receptors type I Alk1/2 Alk1, Alk2  
  Alk3/6 Alk3, Alk6  
  Alk4/5/7 Alk4, Alk5, Alk7  
 Receptors type II TGF-βRII TGF-βRII  
  ActRII ActRII, ActRIIB  
  BMPRII BMPRII, AMHR2  
 Ligands BMP family ADMP ADMP (Kozmikova et al., 2013, Yu et al., 2007) 
  BMP2/4 BMP2, BMP4 (Kozmikova et al., 2013, Panopoulou et al., 1998, 
Yu et al., 2007) 
  BMP3/3b BMP3, GDF10 (Sun et al., 2010) 
  BMP5/8 BMP5, BMP6, BMP7, BMP8 (Kozmikova et al., 2013, Yu et al., 2007) 
  BMP9/10 BMP9, BMP10  
  GDF5/6/7 GDF5, GDF6, GDF7  
 Ligands Activin/Inhibin 1 (Inhibinβ-A, Inhibinβ-B, Inhibinβ-C, Inhibinβ-E ?)  
 TGFβ/Nodal/Activin family Activin/Inhibin 2 (Inhibinβ-A, Inhibinβ-B, Inhibinβ-C, Inhibinβ-E?)  
  Lefty Lefty1, Lefty2 (Morov et al., 2016, Onai et al., 2010, Yu et al., 
2007) 
  Myostatin Myostatin, GDF11  
  Nodal Nodal (Morov et al., 2016, Onai et al., 2010, Yu et al., 
2002, Yu et al., 2007) 
  TGF-β TGF-β TGF-β TGF-β  
  Vg1 GDF1 (Onai et al., 2010) 
 Others BAMBI BAMBI (Yu et al., 2007) 
  Chordin Chordin (Somorjai et al., 2008, Yu et al., 2007) 
  Cerberus Cerberus, DAND5 (Le Petillon et al., 2013, Onai et al., 2010) 
  Gremlin Gremlin1, Gremlin2 (Le Petillon et al., 2013) 
  NBL1 NBL1 (Le Petillon et al., 2013) 
  Tolloid BMP1, Tolloid like 1, Tolloid like 2 (Yu et al., 2007) 
  Tsg Tsg (Yu et al., 2007) 
Wnt     
 Receptors Frizzled 1/2/7 Fzd1, Fzd2 (Qian et al., 2013) 
  Frizzled 4 Fzd4 (Qian et al., 2013) 
  Frizzled 5/8 Fzd5, Fzd8 (Qian et al., 2013) 
  Frizzled 9/10 Fzd9, Fzd10 (Qian et al., 2013) 
 Antagonists sFRP1/2/5 SFRP1, SFRP2/sizzled, SFRP3/FrzB, sFRP5 (Kong et al., 2012, Yu et al., 2007)* 
  sFRP3/4 sFRP4 (Yu et al., 2007) 
  Dkk1/2/4 Dkk1 Dkk2, Dkk4 (Yu et al., 2007, Zhang and Mao, 2010) 
  Dkk3 Dkk3 (Yu et al., 2007, Zhang and Mao, 2010) 
 Co-Receptors LRP5/6 LRP5, LRP6 (Wang et al.) 
  Kremen1, Kremen2, 
Kremen3, Kremen4 
Kremen1, Kremen2 (Zhang and Mao, 2010) 
 Ligands Wnt1 Wnt1 (Holland et al., 2000) 
  Wnt2 Wnt2, Wnt2b/Wnt13 (Somorjai et al., in prep) 
  Wnt3 Wnt3, Wnt3a (Albuixech-Crespo et al., 2017, Schubert et al., 
2001, Somorjai et al., 2008, Yu et al., 2007)  
  Wnt4 Wnt4 (Schubert et al., 2000b) 
  Wnt5 Wnt5a, Wnt5b (Albuixech-Crespo et al., 2017, Schubert et al., 
2001, Somorjai et al., 2008, Somorjai et al., 2012) 
  Wnt6 Wnt6 (Schubert et al., 2001, Somorjai et al., 2008) 
  Wnt7 Wnt7a, Wnt7b (Albuixech-Crespo et al., 2017, Schubert et al., 
2000b, Somorjai et al., 2008)  
  Wnt8 Wnt8a, Wnt8b (Albuixech-Crespo et al., 2017, Morov et al., 2016, 
Schubert et al., 2000c, Yu et al., 2007) 
  Wnt9 Wnt9a, Wnt9b (Somorjai et al., in prep) 
  Wnt10 Wnt10a, Wnt10b (Somorjai et al., in prep) 
  Wnt11 Wnt11 (Schubert et al., 2000a, Yu et al., 2007) 
  Wnt16 Wnt16 (Somorjai et al., in prep) 
 Others Dsh Dvl1, Dvl2, Dvl3 (Wang et al., 2016) 
  Axin Axin1, Axin2 (Beaster-Jones et al., 2008, Wang et al., 2016) 
  GSK3β GSK3β (Wang et al., 2016) 
  β-catenin β-catenin, Plakoglobin  
  TCF TCF1, TCF3, TCF4, LEF1 (Lin et al., 2006) 
  CK1α CK1α (Wang et al., 2016) 
  CK1δ CK1δ (Wang et al., 2016) 
  Groucho Groucho (Wang et al., 2016) 
  APC APC (Wang et al., 2016) 
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large splicing isoform, the authors showed that it is present only 
in neurulating embryos in the somitic mesoderm and in the neural 
plate (Shimeld et al., 2007). 
Another actor for which embryonic expression has been de-
scribed is Sufu (Suppressor of Fused homolog). Sufu is a negative 
regulator of Hh signalling (Fig. 1). It binds to Gli or Ci and impedes 
its translocation into the nucleus (Briscoe and Therond, 2013, Lee 
et al., 2016). In B. belcheri, Sufu is expressed in the same regions 
as Smo (Lin et al., 2009).
Functional studies
Amphioxus mutants for the Hh gene were generated using TALEN 
(Wang et al., 2015). 25% of the F1 embryos showed deformities 
with a curled tail, no mouth and a ventral endostyle and gill slits, 
suggesting a role of Hh pathway in the control of L/R asymmetry in 
amphioxus (Wang et al., 2015). Purmorphamine (Sinha and Chen, 
2006) and Cyclopamine (Chen et al., 2002) are molecules that 
are known to activate and inhibit the Hh pathway, respectively, by 
interacting with Smo. However, up to now there is no study report-
ing the effects of such molecules in amphioxus.
Functional studies have been undertaken in heterologous 
assays to test for the activity of the two Gli isoforms. Using 
different approaches such as mammalian cell transfection, 
chick neural tube electroporation and expression of both 
isoforms in Drosophila imaginal discs, the authors showed 
that the long isoform is an activator of Hh signalling, whereas 
the small isoform acts as a repressor (Shimeld et al., 2007).
Notch pathway
How does it work?
The first Notch gene sequence was described in the 80’s 
in Drosophila (Kidd et al., 1986, Wharton et al., 1985). The 
Notch receptor is a one-pass transmembrane protein with 
extracellular EGF repeats, LIN-12-Notch repeats (LNR) 
and an intracellular specific domain called NICD (Notch 
IntraCellular Domain) containing a RBP-jk association 
module (RAM), nuclear localization signals, ankyrin repeats 
and PEST motifs (proline, glutamic acid, serine, threonine) 
(Wang, 2011). Canonical ligands of Notch are likewise trans-
membrane proteins forming the Delta/Serrate/lag-2 (DSL) 
family, which also present EGF repeats in their extracel-
lular region as well as a conserved so-called DSL domain 
(Wang, 2011). The fact that both receptors and ligands are 
transmembrane proteins implies that the Notch signal can 
only be achieved between contacting cells. Following ligand 
binding, the Notch receptor is first cleaved by metalloprote-
ases releasing the ectodomain, and then by a g-secretase 
complex that frees the NICD, which can translocate into 
the cell nucleus and interact with the DNA-binding protein 
CSL (CBF1/RBPjκ/Su(H)/Lag-1) (Kopan and Ilagan, 2009) 
(Fig. 4). Together, NICD and CSL recruit the coactivator 
Mastermind/Lag-3, leading to transcriptional activation of 
target genes (Kopan and Ilagan, 2009) (Fig. 4). Although a 
panel of genes coding for regulators of the Notch pathway 
exists in the amphioxus genome (Gazave et al., 2009), we 
will mainly focus our attention on genes for which expres-
sion patterns have been described.
Fig. 2. Late embryonic development in amphioxus. (A) Pictures of lateral and 
dorsal view of the same late neurula stage embryo are shown together with small 
schemes presenting the different presumptive structures that are found in the 
anterior region. Scale bar, 50mm. (B) Pictures of the anterior region of a larva on 
its left and right side are shown together with schemes highlighting the different 
pharyngeal structures that are formed at this stage. The frontal eye is indicated by 
a white arrowhead and the first pigment spot by a double arrowhead. Scale bar, 
50mm. Colour code is according to Fig. 1.
Receptors and ligands in amphioxus
In vertebrates, four receptors are known, at least in mammals. 
In amphioxus, one Notch receptor gene has been described in B. 
floridae, which is orthologous to vertebrate Notch1/2/3/4 (Holland 
et al., 2001). The Notch protein contains 36 EGF repeats, 3 LNR, 
a transmembrane region, a RAM domain, 6 ankyrin repeats and 
several sites for proteolytic cleavage, which are required for Notch 
signalling pathway activation. Transcripts are first detected by in 
situ hybridization at the gastrula stage, in a ring of presumptive 
mesendoderm (Holland et al., 2001). Subsequently, a gradient in 
the dorsal mesendoderm is observed with higher expression in the 
posterior region (Holland et al., 2001). In the neurulating embryo, 
strong Notch expression is detected in the posterior mesoderm 
and in the dorsal part of the three most anterior somites (Holland 
et al., 2001). While the embryo is elongating, Notch transcripts are 
expressed in the second-youngest somites and in the neural plate 
and forming notochord (Holland et al., 2001). Thereafter, expres-
sion in the somites gets more intense in their posterior part, and 
becomes stronger in the forming neural tube (Holland et al., 2001). 
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TABLE 2
SUMMARY OF PHENOTYPES OBTAINED AFTER PHARMACOLOGICAL TREATMENTS 
INTERFERING WITH DIFFERENT SIGNALLING PATHWAYS
Pathways Molecules Targets Concentrations, stages Effects References 
Notch      
 DAPT (N-[N-(3,5-
difluorophenacetyl)-l-alanyl]-S-
phenylglycine t-butyl ester) 
γ-secretase inhibitor 50µM (continuous from late gastrula) Ectopic epidermal sensosry cells (Lu et al., 2012) 
   50–100µM (continuous from late blastula) Incomplete formation of the somites 
segmental boundary 
Incorrect dorso-ventral segregation of 
somites 
(Onai et al., 2015) 
 Compound E γ-secretase inhibitor not specified Ectopic epidermal sensosry cells (Lu et al., 2012) 
 L-685458 γ-secretase inhibitor not specified Ectopic epidermal sensosry cells (Lu et al., 2012) 
RAR      
 all-trans Retinoic Acid (ATRA) Agonist of RAR 1nM to 1µM (continuous from blastula stage) Posteriorization of the embryo (Holland and Holland, 
1996) 
   1µM (continuous from blastula stage) Posteriorization of the embryo (Escriva et al., 2002) 
   1µM (continuous from blastula stage) Posteriorization of epidermal sensory 
neurons 
(Schubert et al., 2004) 
   1µM (continuous from blastula stage) Posteriorization of the pharynx (Schubert et al., 2005) 
   1µM (continuous from early gastrula stage) Anteroposterior patterning defects in 
gastrula 
(Koop et al., 2010) 
   1µM (continuous from blastula stage) Hox genes expression expansion 
anteriorly, less motor neurons. 
(Schubert et al., 2006) 
   1µM (continuous from 6-8 gill slit larvae to 8-10 
gill slit larvae) 
Tail regression (Koop et al., 2011) 
   1µM (continuous from early gastrula stage) Inhibition of hematopoiesis (Pascual-Anaya et al., 
2013) 
   1µM (continuous from early-mid neurula, mid-
neurula and late neurula to larval stage) 
Shortening of the pharynx and loss of 
pharyngeal structures 
(Koop et al., 2014) 
 BMS009 Antagonist of RAR 1.5µM (continuous from blastula stage) Anteriorization of the embryo (Escriva et al., 2002) 
   1µM (continuous from blastula stage) Anteriorization of epidermal sensory 
neurons 
(Schubert et al., 2004) 
   1µM (continuous from blastula stage) Anteriorization of the pharynx (Schubert et al., 2005) 
   1µM (continuous from early gastrula stage) Anteroposterior patterning defects in 
gastrula 
(Koop et al., 2010) 
   1µM (continuous from blastula stage) Hox genes expression  anterior limit 
shifted posteriorly, more motor neurons 
(Schubert et al., 2006) 
   2µM (continuous from early-mid neurula, mid-
neurula and late neurula to larval stage) 
Expansion of the pharynx (Koop et al., 2014) 
   1µM (continuous from late blastula stage) Enlarged pharynx and expansion of 
pharyngeal structures 
(Carvalho et al., 2017) 
 BMS493 Antagonist of RAR 1µM (continuous from late blastula stage) Enlarged pharynx and expansion of 
pharyngeal structures, tail fin 
elongation 
(Carvalho et al., 2017) 
 R115866 Inhibitor of Cyp26  500nM (continuous frome eraly gastrula stage) Shortening of the pharynx and loss of 
pharyngeal structures 
(Koop et al., 2014) 
   0,1 to 0,5µM (continuous from late blastula 
stage) 
Shortening of the pharynx and 
malformation of pharyngeal structures, 
tail fin reduction 
(Carvalho et al., 2017) 
TR      
 Triiodothyronine (T3) Agonist of TR 10-100nM (continuous treatment from 
premetamorphic larval stage) 
Induction of metamorphosis (Paris et al., 2008) 
 Thyroxine (T4) Agonist of TR 10-100nM (continuous treatment from 
premetamorphic larval stage) 
Induction of metamorphosis (Paris et al., 2008) 
 Triiodothyroacetic acid (TRIAC) Agonist of TR 10nM (continuous treatment from 
premetamorphic larvae) 
Induction of metamorphosis (Paris et al., 2008) 
TGF-β      
 Dorsomorphin Inhibitor of BMP Type I 
receptor 
8/16µM (continuous from late gastrula stage) Reduction of the number epidermal 
sensosry cells 
(Lu et al., 2012) 
   20µM (continuous from early blastula stage) Partial dorsalization of the embryo (Kozmikova et al., 2013) 
   5/10/25µM 
(continuous from Knife shaped larval stage) 
Mouth formation/opening affected (Kaji et al., 2016) 
   35µM (continuous from early blastula stage) Dorsalization of the mesendoderm 
and absence of ectodermal cells 
specification 
(Le Petillon et al., 2017) 
 LDN-193189 Inhibitor of BMP Type I 
receptor 
3µM (continuous from early blastula stage) Partial dorsalization of the embryo (Kozmikova et al., 2013) 
 zBMP4  250ng/ml (continuous from early blastula stage) Ventralization of the embryo (Lu et al., 2012, Yu et al., 
2008, Yu et al., 2007) 
    Loss of neural pate border genes 
expression 
(Yu et al., 2008) 
   250ng/ml (continuous from late gastrula stage) Ectopic epidermal sensosry cells (Lu et al., 2012) 
 mBMP2  250ng/ml (continuous from early blastula stage) Ventralization and posteriorization of 
the embryo 
(Kozmikova et al., 2013) 
 hActivin  10ng/ml (continuous from early blastula stage) Dorsalization and anteriorization of the 
embryo 
(Onai et al., 2010) 
   50ng/ml (treatment before early gastrula stage 
on ectodermal explants) 
The whole ectoderm expresses neural 
markers 
(Le Petillon et al., 2017) 
 mNodal  8µg/ml 
(continuous from early gastrula stage) 
Loss of asymmetrical expression Nodal 
pathway genes 
(Li et al., 2017) 
 SB505124 Inhibitor of  
TGF-β/Nodal/Activin 
Type I receptor 
5/10µM (continuous from late gastrula stage) Loss of asymmetry (Bertrand et al., 2015, 
Soukup et al., 2015) 
   50µM (continuous from early gastrula stage) Loss of asymmetrical expression of 
Nodal pathway genes 
(Li et al., 2017) 
   5µM (from prehatching neurula to hatching 
neurula stage) 
Loss of orobranchial structures (Kaji et al., 2016) 
   50µM (continuous from early gastrula stage) Ventralization of the embryo (Onai et al., 2010) 
   50µM (continuous from early blastula stage) Ventralization of the embryo (Kozmikova et al., 2013) 
   1µM (continuous from early gastrula stage) Loss of dorsal structures (Onai et al., 2012) 
   50µM (continuous from one cell stage) Reduced blastopore diameter (Morov et al., 2016) 
 SB431532 Inhibitor of  
TGF-β/Nodal/Activin 
Type I receptor 
5/10/20µM 
(continuous from late gastrula stage) 
Loss of asymmetry (Bertrand et al., 2015, 
Soukup et al., 2015) 
FGFR      
 SU5402 Inhibitor of FGFR 50µM (continuous from 8-cell stage) Gastrulation defects (Bertrand et al., 2011) 
   50µM (continuous from blastula stage) Absence of anterior somites (Bertrand et al., 2011) 
   50µM (continuous from late neurula stage) Malformation of the notochord (Bertrand et al., 2011) 
PD/VEGFR      
 SU5416 Inhibitor of PD/VEGFR 0,1-20µM (continuous from early gastrula stage)  Curved tail (Pascual-Anaya et al., 
2013) 
Wnt      
  Inhibitor of GSK3-β 
 
Loss of anterior markers expression; 
forebrain truncation, posteriorization 
(Onai et al., 2009) 
   400mM (30 min from early blastula stage)  Exogastrula  (Holland et al., 2005) 
   Various concentrations (from early blastula 
stage) 
Posteriorization and lack of neural 
plate; severity is concentration 
dependent 
(Holland et al., 2005) 
   50 to 100mM (1-128 cell stage) Early effect: abnormal cell divisions 
and apparent loss of polarity; late 
effect: gastrulation and elongation 
defects 
(Yasui et al., 2002) 
 BIO Inhibitor of GSK3-β 0.5 µM for 30min at early gastrula stage Disruption of early polarity, 
posteriorization and elongation defects, 
downregulation of anterior ectoderm 
and CNS markers  
(Onai et al., 2012) 
 Alsterpaullone Inhibitor of GSK3-β 0.75-1.5µM Reduction of forebrain and pharynx as 
assessed by Otx expression; more 
severe elongation defects than with 
lithium 
(Onai et al., 2009) 
 Azakenpaullone Inhibitor of GSK3-β 10 µM (continuous from late gastrula to early 
neurula or larva) 
Loss of Sp5 expression and expansion 
of Bra2 posterior expression; loss of 
anterior-most structures by larval 
stages 
(Dailey et al., 2017) 
 CHIR99021 Inhibitor of GSK3-β 10 µM; cleavage to gastrula  Increase of Sp5 expression (Dailey et al., 2017) 
 
Li+/LiCl  30 min at onset of gastrulation; Na+
 
substituted 
for Li+ in seawater 
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γ-secretase inhibitor 50µM (continuous from late gastrula) Ectopic epidermal sensosry cells (Lu et al., 2012) 
   50–100µM (continuous from late blastula) Incomplete formation of the somites 
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(Onai et al., 2015) 
 Compound E γ-secretase inhibitor not specified Ectopic epidermal sensosry cells (Lu et al., 2012) 
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   1µM (continuous from blastula stage) Posteriorization of the embryo (Escriva et al., 2002) 
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elongation 
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 Triiodothyronine (T3) Agonist of TR 10-100nM (continuous treatment from 
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premetamorphic larval stage) 
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 Dorsomorphin Inhibitor of BMP Type I 
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8/16µM (continuous from late gastrula stage) Reduction of the number epidermal 
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   20µM (continuous from early blastula stage) Partial dorsalization of the embryo (Kozmikova et al., 2013) 
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(continuous from Knife shaped larval stage) 
Mouth formation/opening affected (Kaji et al., 2016) 
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specification 
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   250ng/ml (continuous from late gastrula stage) Ectopic epidermal sensosry cells (Lu et al., 2012) 
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   50ng/ml (treatment before early gastrula stage 
on ectodermal explants) 
The whole ectoderm expresses neural 
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 mNodal  8µg/ml 
(continuous from early gastrula stage) 
Loss of asymmetrical expression Nodal 
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 SB505124 Inhibitor of  
TGF-β/Nodal/Activin 
Type I receptor 
5/10µM (continuous from late gastrula stage) Loss of asymmetry (Bertrand et al., 2015, 
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   50µM (continuous from early gastrula stage) Loss of asymmetrical expression of 
Nodal pathway genes 
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   5µM (from prehatching neurula to hatching 
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   50 to 100mM (1-128 cell stage) Early effect: abnormal cell divisions 
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(Yasui et al., 2002) 
 BIO Inhibitor of GSK3-β 0.5 µM for 30min at early gastrula stage Disruption of early polarity, 
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assessed by Otx expression; more 
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of Bra2 posterior expression; loss of 
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Fig. 3. Simplified schematic 
view of the canonical hedge-
hog (Hh) signalling pathway. 
In the ligand producing cell, 
Hh undergoes autoproteo-
lytic cleavage releasing the 
N-terminal domain (HH-N) from 
the C-terminal domain (HH-C). 
HH-N is subsequently linked 
to a palmitate in its N-terminus 
and to a cholesterol molecule in 
its C-terminus, probably in the 
endoplasmic reticulum (ER). 
In the absence of Hh (OFF), 
the transmembrane receptor 
Patched inhibits the orphan 
GPCR Smoothened (Smo), 
leading to the proteolysis of 
the transcription factor Gli, se-
questered by Sufu (Suppressor 
of Fused homolog), which is 
converted into its repressor form 
(Gli-R). Gli-R acts by repressing the transcription of Hh pathway target genes in the nucleus. When Hh binds to Patched (ON), Smoothened inhibition 
is released leading to the dissociation of Gli from Sufu. Gli is therefore in its active form (Gli-A) and enters the nucleus to activate the transcription of 
Hh pathway target genes.
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At the late neurula stage, a new expression domain is observed in 
the anterior pharyngeal endoderm (Holland et al., 2001). At later 
stages, Notch is expressed in the tailbud, the cerebral vesicle and 
Hatcheck’s left diverticulum (Holland et al., 2001). The expression 
of Notch has also been analyzed in B. lanceolatum, where it was 
shown to be quite similar to that in the Florida species. However, 
expression in the pharyngeal endoderm and cerebral vesicle can 
also be detected at an earlier developmental stage (mid-neurula) 
in the European species (Somorjai et al., 2008).
In vertebrates at least 5 ligands are known: Jagged1 and 2 and 
Delta-like 1, 3, and 4 (Wang, 2011). Although two genes for ligands 
of the Jagged family have been found in the B. floridae genome 
(Gazave et al., 2009), only cloning and expression of the single 
Delta gene, orthologous to vertebrate Delta-like genes (Gazave 
et al., 2009), was reported (Rasmussen et al., 2007). The Delta 
protein of amphioxus contains a signal peptide, a DSL domain and 
nine EGF repeats (Rasmussen et al., 2007). Delta expression, 
as for Notch, is first observed at the gastrula stage, in the dorsal 
mesendoderm region (Rasmussen et al., 2007). Then, expression 
becomes restricted to the paraxial mesoderm and is observed after 
hatching in the two first pairs of somites before they begin to form, 
and in some cells of the neural plate (Rasmussen et al., 2007). 
As development proceeds, transcripts are also detected in some 
epidermal cells in the ventral region (Rasmussen et al., 2007). At 
the late neurula stage, Delta is expressed in the posterior part of 
somites, in some neural plate cells, in ectodermal cells on both 
sides of the embryo, and in the pharyngeal endoderm (Rasmus-
sen et al., 2007). In the larva, expression is mainly observed in 
the forming somites budding from the tailbud, in some cells of 
the club-shaped gland and in the most anterior pharyngeal cells 
(Rasmussen et al., 2007). 
It is interesting to note that the expression patterns of Notch 
and Delta are not fully overlapping. Concerning the expression of 
Notch in territories in which Delta is not expressed, we might expect 
another ligand coding gene (from the Jagged family possibly) to be 
transcribed, although we cannot exclude Notch activation through 
a non-canonical pathway (Andersen et al., 2012) in such regions.
Other actors
The only other actor of the Notch pathway for which expression 
data are available is Fringe (Mazet and Shimeld, 2003), the ohnolog 
of lunatic fringe, radical fringe and manic fringe in vertebrates. Fringe 
proteins are glucosaminyltransferases that have been shown to 
modulate Notch activity by initiating elongation of O-linked fucose 
residues attached to the EGF repeats of its ectodomain (Bruckner 
et al., 2000, Moloney et al., 2000). In a first study, amphioxus 
Fringe expression was detected at the late gastrula stage in the 
anterior neural plate (Mazet and Shimeld, 2003). Then, neural 
expression becomes segmented as somites start to form, and 
Fringe transcripts are detected in the posterior endoderm and in 
the endodermal cells that are fated to become the dorsal midline 
of the embryonic gut (Mazet and Shimeld, 2003). In late neurula 
stage embryos, Fringe is expressed in the cerebral vesicle and in 
the anterior and posterior endoderm (Mazet and Shimeld, 2003). In 
a more recent study, Fringe expression was detected earlier during 
gastrulation, in the ventral mesendoderm, with a dorsal boundary 
just adjacent to the Delta expressing paraxial mesoderm territory 
(Onai et al., 2015).
Functional studies
Notch pathway function has mainly been studied using treatments 
with DAPT (N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine 
t-butyl ester), a g-secretase inhibitor (Dovey et al., 2001) that in-
hibits Notch receptor cleavage, thereby impeding Notch pathway 
activation by any ligand. Amphioxus possesses a dorsal central 
nervous system and a peripheral nervous system composed of 
several populations of epidermal sensory neurons (ESNs) (Wicht 
and Lacalli, 2005). Among these cells, the type I solitary neurons 
are the most abundant, and their progenitors express Delta, to-
gether with the neural bHLH factor achaete-scute homologue at 
the neurula stage (Lu et al., 2012). Lu and colleagues showed that 
inhibiting the Notch pathway using DAPT, and other g-secretase 
inhibitors, induces the formation of more ESN progenitors, which 
are then grouped in clusters containing more cells than in control 
embryos (Lu et al., 2012). This experiment suggests that Delta/
Fig. 4. Simplified schematic view 
of the canonical Notch signalling 
pathway. When a Notch family 
receptor interacts with its trans-
membrane ligand produced by a 
neighbouring cell, the extracellular 
domain is first cleaved by extracel-
lular metalloproteases. The Notch 
intracellular domain (NICD) is then 
released after intracellular cleavage 
by a g-secretase complex. NICD then 
enters the nucleus where it interacts 
with a DNA binding protein, CSL 
(CBF1/RBPjκ/Su(H)/Lag-1). Together 
they recruit a co-activator called 
Mastermind (MAM) to activate the 
transcription of target genes.
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Notch-mediated lateral inhibition would be required in amphioxus 
for the specification of individual sensory neurons, as is the case 
in other animals like Drosophila (Lu et al., 2012). In vertebrates, 
the Delta/Notch pathway is implicated in the segmentation of the 
paraxial mesoderm, which forms somites. Onai and colleagues stud-
ied the role of Notch signalling during somitogenesis in amphioxus 
(Onai et al., 2015). They showed that after DAPT treatments, the 
enterocoelic somites, which normally form from the paraxial dorsal 
mesendoderm, are not completely separated from the archenteron 
roof, and that the boundaries between somites are not apparent 
(Onai et al., 2015). The authors suggest that in amphioxus, the 
Notch signal would be important for the correct dorso-ventral 
segregation of somites as well as for antero-posterior boundary 
formation between somites (Onai et al., 2015).
Nuclear receptors
How do they work?
Nuclear receptors (NRs) are ligand-activated transcription factors 
that consist of a modular structure comprising two major functional 
domains. These include the N-terminal domain (i.e. DNA binding 
domain, DBD), which is responsible for the interaction between 
the NRs and the response elements present in the promoter re-
gion of their target genes, and the C-terminal domain (i.e. ligand 
binding domain, LBD), which interacts with the ligands and with 
co-regulators to control gene expression (Gronemeyer et al., 2004). 
Thus, NRs occupy a special position in gene regulation since they 
provide a direct link between the ligand, which they bind, and the 
target genes, whose expression they regulate. However, not all 
NRs have a ligand and some of them, the so-called orphan recep-
tors, either function through the binding of an unknown ligand, or 
control expression of their target genes without binding any ligand 
(Benoit et al., 2006). Known ligands in vertebrates include many 
different lipophilic molecules of different chemical natures, such 
as steroids, thyroid hormones, retinoic acid, or even fatty acids 
(Robinson-Rechavi et al., 2003). Mammalian genomes contain 
48-49 different NRs, grouped into 7 subfamilies (NR0-NR6) includ-
ing 19-20 paralogy groups (Escriva Garcia et al., 2003). The B. 
floridae genome contains 33 NRs, including members of all the 
mammalian paralogy groups except two (NR1I/J/K and NR2F) 
(Schubert et al., 2008). However, a NR2F gene has been cloned 
and studied (COUP-TF), indicating that genome data are incomplete 
(Langlois et al., 2000). Moreover, amphioxus also has a member 
of the NR5B subfamily, which is not present in vertebrates and 
was only known in ecdysozoans; and a member of a completely 
new subfamily, NR7, which is not present in vertebrates but that 
has been found in echinoderms. Furthermore, amphioxus shows 
some lineage specific duplications for the NR1H and the NR2E 
subfamilies. Analyses of gene expression and functional studies 
have only been undertaken for a few of the amphioxus NRs. We 
will detail below expression and functional data for these receptors.
Expression patterns of nuclear receptors
Gene expression has been studied for only a few NRs in amphi-
oxus, including NR1A (Paris et al., 2008a) and NR1B (Escriva et al., 
2002) (thyroid hormone receptor – TR, and retinoic acid receptor 
– RAR, respectively), NR2B (RXR) (Escriva et al., 2002), NR2C 
(TR2/4) (Escriva et al., 2002), NR2F (COUP-TF) (Langlois et al., 
2000), NR3A, B and C (ER, ERR and SR, respectively) (Bardet et 
al., 2005, Bridgham et al., 2008) and NR4A (Nurr1/NGFIB/NOR1) 
(Candiani et al., 2009).
The biological functions of retinoic acid (RA) are mediated by 
heterodimers of two NRs: RAR and RXR. RXR also acts as an 
heterodimer of other nuclear receptors in accordance with its broad 
and weak expression throughout all developmental stages in amphi-
oxus (Escriva et al., 2002). In contrast, by the mid-gastrula stage, 
RAR is expressed throughout the mesendoderm and more weakly 
throughout the ectoderm. At the early neurula stage expression 
becomes downregulated anteriorly in the different tissues where it 
is expressed (i.e. the neural plate, the anterior endoderm and the 
non-neural ectoderm), but remains high in the posterior mesoderm, 
somites and in the posterior three-quarters of the neural plate and 
endoderm (Escriva et al., 2002). Later on, at the mid-neurula stage, 
expression is also downregulated in the posterior third of the en-
doderm, and the only remaining strong expression is in the nerve 
cord, posterior to the cerebral vesicle, in the somites of the middle 
third of the embryo and in a small region of the endoderm. In late 
neurulae, RAR expression is limited to the nerve cord posterior 
to the cerebral vesicle and to the endoderm at low levels. Finally, 
in larvae, RAR is expressed only in the middle third of the nerve 
cord, somites and gut (Escriva et al., 2002).
TR2/4 shows an expression pattern complementary to RAR 
(Escriva et al., 2002). Thus, expression is first detected at the early 
neurula stage in the anterior neuroectoderm, particularly in the future 
cerebral vesicle, and in the dorso-anterior endoderm. Later on, at 
the mid-neurula stage, expression is most intense posteriorly and 
anteriorly, especially in the posterior mesoderm, cerebral vesicle 
and Hatcheck’s left diverticulum, which is homologous to part of 
the vertebrate pituitary. In late neurulae, expression is strong in the 
cerebral vesicle, in Hatschek’s left diverticulum and in the primordia 
of the mouth and first gill slit. There is also weak expression in the 
gut. At the late neurula stage, before the mouth opens, expression 
persists in the tailbud, cerebral vesicle and in pharyngeal structures 
(in the forming mouth, first gill slit and Hatschek’s left diverticulum). 
This expression remains until the larval stage except in the tailbud 
(Escriva et al., 2002).
Gene expression of the amphioxus thyroid hormone receptor (TR) 
has only been studied quantitatively using RT-qPCR. The authors 
showed that TR expression is low during embryonic development, 
increases in pre-metamorphic larvae just before metamorphosis, 
and then decreases in juveniles and adults (Paris et al., 2008a).
The amphioxus orthologue of COUP-TF NRs is not expressed 
during early development and transcripts only start to be detected 
by in situ hybridization at the late larval stage (4-5 gill slit larvae) in 
the neural tube posterior to the cerebral vesicle, the homologue of 
the vertebrate hindbrain and spinal cord, and in dorsal and lateral 
groups of cells which form dorso-ventral stripes in the nerve cord 
(Langlois et al., 2000).
The estrogen related receptor gene (ERR) shows an interest-
ing expression pattern during amphioxus embryonic development 
(Bardet et al., 2005). Transcripts are first detected at the neurula 
stage in the dorsal part of somites 2 to 6, and then in the newly 
formed somites when the neurula elongates. From the mid-neurula 
stage, ERR starts to be expressed in individual mesodermal and 
epidermal cells, but this expression disappears in later stages when 
ERR starts to be weakly expressed in the pharyngeal endoderm. 
Other expression sites at mid-neurula stage are the frontal eye, the 
presumptive photoreceptor of Hesse and other neuronal derivatives. 
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ERR is expressed from this developmental stage in paired cells in 
the neural tube, from the border between somites 1 and 2 up to 
somite 4, and this pattern is extended in later stages until labelling 
is observed in six pairs of cells. This segmented pattern remains 
until the larval stage when a new expression domain appears in 
the posterior part of the cerebral vesicle (Bardet et al., 2005).
Expression studies for other NRs of subfamily 3 have also been 
published, but only in adults. Thus, while estrogen receptor (ER) 
and steroid receptor (SR) genes are co-expressed in the cyto-
plasm of the oocytes in the female gonads, only ER is expressed 
weakly in the gills. In males, SR is expressed broadly throughout 
the testes, at all stages of spermatogenesis, and ER is expressed 
in the germinal epithelium of the testis in a narrow band of cells 
that are likely to be early spermatogonia (Bridgham et al., 2008).
The last NR for which gene expression has been documented 
is the orthologue of Nurr1/NGFIB/NOR1, which shows a restricted 
expression pattern in late neurula stage embryos in the ventro-
medial wall of the Hatschek’s left diverticulum and in the posterior 
region of the pre-oral pit of larvae (Candiani et al., 2009).
Other actors
Nuclear receptor-mediated transactivation of target genes 
implies direct contact between the receptor and co-regulators (co-
activators or co-repressors). Although orthologues of vertebrate 
co-regulators are present in the B. floridae genome (Schubert et al., 
2008), no expression or functional data have been published. How-
ever, several studies have shown that mammalian co-regulators 
are able to interact with several amphioxus NRs. Thus, amphioxus 
TR in the presence of its ligand TRIAC (3,5,3’-triiodothyroacetic 
acid) interacts with the co-activator SRC-1 (Steroid Receptor 
Coactivator 1) (Paris et al., 2008a), amphioxus RXR interacts with 
the co-activator hTIF2 (human Transcriptional Intermediary Factor 
2) in the presence of its ligand 9-cis RA (Tocchini-Valentini et al., 
2009) and amphioxus ERRs (there are two isoforms of this receptor 
in amphioxus, long and short ERR), interact with the mammalian 
SRC-1, GRIP1 (Glutamate Receptor Interacting Protein 1), TIF1 
(Transcriptional Intermediary Factor 1) and RIP140 (Receptor-
Interacting Protein 140) (Horard et al., 2004). 
Other actors playing important roles in NR signalling pathways 
are enzymes implicated in ligand anabolism and catabolism. 
However, while the presence of many genes for these enzymes 
has been described in amphioxus (e.g. enzymes implicated in 
steroid metabolism such as cytochrome P450 (CYP11A, CYP17, 
and CYP19) and the 17b-hydroxysteroid dehydrogenase) (Castro 
et al., 2005, Mizuta and Kubokawa, 2007), gene expression and/
or function has only been characterized for enzymes involved in 
the synthesis and degradation of RA, and for CYP19 aromatase. 
Using semi-quantitative RT-PCR, it was shown that the CYP19 is 
expressed in the middle third of amphioxus adults and preferentially 
in females (Callard et al., 2011, Castro et al., 2005). Other enzymes 
for which the expression pattern has been characterized include 
the retinoic acid degradation enzyme CYP26. Three CYP26 genes 
(CYP26 1-3), which originated by tandem duplication, are found 
in amphioxus (Carvalho et al., 2017). The expression profiles of 
CYP26-1 and CYP26-3 are quite similar and weak, starting at 
the mid-gastrula stage in the lateral anterior mesoderm. Then, in 
mid-neurulae, expression is detected in the anterior somites and 
in the anterior central nervous system. A slight difference is then 
found in the larvae where CYP26-1 is more strongly expressed in 
central and posterior regions, whereas CYP26-3 labelling is more 
intense in central and anterior regions. The expression of CYP26-2 
starts at the mid-gastrula stage around the blastopore and, later, an 
expression domain appears in the presumptive lateral mesoderm 
and anterior neuroectoderm. At the mid-neurula stage, expression 
is detected in the anterior somites and neuroectoderm, but also in 
the most anterior and posterior tips of the ectoderm and endoderm 
and in the tailbud. In late neurulae, before the mouth opens, it is 
expressed in all anterior germ layers and at the posterior end in 
the ectoderm. Finally, in larvae, the overall domains of CYP26-2 
expression are maintained, with conspicuous labelling anteriorly 
and posteriorly and a weaker signal in the centre (Carvalho et 
al., 2017). RA producing enzyme (aldehyde dehydrogenases, 
ALDHs) expression patterns have also been studied in amphioxus 
(Sobreira et al., 2011), which possesses 6 ALDH1 genes and one 
ALDH2 (Canestro et al., 2006). Amphioxus ALDH1a is expressed 
caudally close to the developing tailbud with a sharp anterior 
boundary at the mid-neurula stage (Sobreira et al., 2011). Later, 
it is detectable in the posterior gut endoderm of late neurulae. 
The expression of ALDH1d overlaps with that of ALDH1a at the 
mid-neurula stage, but in late neurulae, expression is broad and 
slightly stronger in the posterior gut (Sobreira et al., 2011). Other 
ALDH1 genes, such as ALDH1b, ALDH1c, ALDH1e, and ALDH1f 
are weakly expressed in posterior domains overlapping with that 
of ALDH1a in mid-neurula stage embryos (Sobreira et al., 2011). 
However, by the late neurula, they are expressed diffusely and 
weakly throughout the amphioxus embryo with a weak to moderate 
concentration of the signal for ALDH1b, ALDH1c, and ALDH1e 
in the posterior gut (Sobreira et al., 2011). ALDH2 expression is 
restricted to posterior mesendodermal tissues at the mid-neurula 
stage and, subsequently, spreads throughout the embryo in late 
neurulae (Sobreira et al., 2011).
Functional studies
Pharmacological treatments with molecules that are agonist or 
antagonist ligands of NRs have been used to study the function of 
NRs during embryonic development in amphioxus. In this context, 
the most studied function has been the role of RA during embryonic 
development using all-trans RA itself as well as RA antagonists 
(BMS009, BMS493). An excess of RA induces a posteriorization 
of the embryo, whereas the use of antagonists of RAR induces 
anteriorization (Escriva et al., 2002). This role of RA in antero-
posterior patterning starts at the early gastrula stage (Koop et 
al., 2010) and affects different tissues, such as the ectoderm, 
through the control of antero-posterior patterning of epidermal 
sensory neurons (Schubert et al., 2004); or the endoderm, where 
RA establishes the posterior limit of the pharynx through control 
of Hox1 expression (Schubert et al., 2005). Besides this role in 
patterning, RA also controls pharynx segmentation (Koop et al., 
2014), neuronal specification (Schubert et al., 2006), or even tis-
sue remodelling in the amphioxus tail (Koop et al., 2011) and tail 
fin formation (Carvalho et al., 2017). Finally, treatment of neurula 
stage embryos with RA was shown to inhibit hematopoiesis in 
amphioxus (Pascual-Anaya et al., 2013). 
Another receptor for which the developmental function has been 
studied is TR. It has been shown that amphioxus metamorphosis 
is controlled by a thyroid hormone, the 3,5,3’-triiodothyroacetic 
acid (TRIAC), through its binding to TR and its activation (Paris 
et al., 2008a).
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Other functional studies on amphioxus NRs concern their mo-
lecular capacities to bind DNA and to homo- or heterodimerize. 
Using in vitro EMSA (Electro Mobility Shift Assay) approaches,TR 
has been shown to bind both as homo- or heterodimer with RXR to 
DR4 (Direct repeat 4) and HREpal (Hormone Response Element 
palindrome) elements (Paris et al., 2008a). RAR heterodimerizes 
with RXR and binds classical DR5 response elements, as well as 
an IR7 (Inverted Repeat 7) element found in the 5’ non coding 
region of TR2/4. This receptor, TR2/4, also binds to this IR7 and 
to DR5 elements (Escriva et al., 2002). In addition, RXR binds 
as a heterodimer with TR and RAR to DR4 and DR5 elements, 
respectively, and as a homodimer to DR1 elements (Escriva et 
al., 2002). COUP-TF can bind elements ranging from DR0 to DR5 
with different affinities (Langlois et al., 2000). Finally, receptors of 
the NR3 subfamily (i.e.; ERR, ER, SR) bind ERE (Estrogen Re-
sponse Element). Thus, ERR, which is expressed as two isoforms 
(a short and a long isoform), binds ERE as homo- or heterodimers 
formed by the two isoforms, or to SFRE (Steroidogenic Factor 
Binding Element) as a homodimer for the short isoform, and as 
monomer for the long isoform (Horard et al., 2004). ER and SR 
also bind to ERE as homodimers (Bridgham et al., 2008, Paris 
et al., 2008a). These results show that, globally, amphioxus NRs 
function in a similar way as their vertebrate orthologues, except 
for SR, which can bind ERE, in contrast to its vertebrate ortho-
logues AR (Androgen Receptor), MR (Mineralocorticoid Receptor), 
PR (Progesterone Receptor) and GR (Glucocorticoid Receptor) 
(Bridgham et al., 2008). 
The ligand binding capacity of different NRs has also been 
tested either directly (using limited proteolysis assays or mass 
spectrometry) or indirectly (using a transactivation assay after 
transient transfection). Thus, RAR binds all-trans and 9-cis RA 
(Escriva et al., 2006), similarly to its vertebrate orthologues with 
similar affinities, but TR does not bind vertebrate thyroid hor-
mones (triiodothyronine (T3) or thyroxine (T4)). However, a new 
ligand was discovered in amphioxus which is a thyroid hormone 
derivative, TRIAC, that binds with high affinity to the amphioxus 
TR (Paris et al., 2008a). Other receptors for which ligand binding 
has been studied are RXR, which binds several molecules such 
as 9-cis RA, DHA (DocosaHexaenoic Acid) or oleic acid (with 
lower affinities than vertebrate RXRs) (Tocchini-Valentini et al., 
2009). TR2/4 does not bind any ligand but is able to transactivate 
expression of a reporter gene controlled by an IR7 element and 
also to inhibit the transactivation of the RAR-RXR heterodimer by 
competing for the DR5 response element (Escriva et al., 2002). 
Fig. 5. Simplified schematic view of the receptor tyrosine kinase (RTK) canonical signalling pathway. RTK are transmembrane receptors and 
interaction of dimers with their ligands induces a transphosphorylation on tyrosine residues of the intracellular domain. The phosphorylated cytoplasmic 
domain interacts with the adaptor protein Grb2 (Growth factor receptor-bound protein 2), which is associated with the Ras-guanine exchange factor Sos 
(Son of sevenless) that transforms Ras-GDP into Ras-GTP. This is the first step of activation of the MAPK (Mitogen-activated protein kinase) cascade, 
which ends with the activation of target gene transcription. Phosphorylated receptors also interact with PI3K (phosphatidylinositide 3-kinase) and PLCg. 
Active PI3K then activates Akt whereas PLCg (Phospholipase C-g) catalyzes the formation of two secondary messengers, inositol 1,4,5-trisphosphate 
(IP3) and diacylglycerol (DAG), from phosphatidylinositol 4,5-bisphosphate (PIP2). IP3 diffuses in the cytoplasm and, through interaction with its recep-
tor, induces the release of Ca2+ from the endoplasmic reticulum resulting in an increase of Ca2+ cytoplasmic concentration. DAG activates PKC (Protein 
Kinase C), which phosphorylates several substrates. The integration of the activation of the three intracellular cascades leads to many different outputs 
at the cellular level.
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COUP-TF is also able to inhibit receptor-mediated activation 
of transcription of different mouse receptors bound to different 
response elements from DR1 to DR5 and ERE (Langlois et al., 
2000). The orphan receptor ERR can also transactivate through 
an ERE (both long and short isoforms); however, on an SFRE, 
only the short isoform can transactivate, while the long isoform 
has no effect (Horard et al., 2004). The other steroid receptors, ER 
and SR, do not behave as classical vertebrate steroid receptors 
in amphioxus. Thus, amphioxus ER does not bind estrogens and 
it has only been shown to bind BPA (bisphenol A). In contrast, SR 
binds estrogens with low affinity (Bridgham et al., 2008, Paris et 
al., 2008b). Thus, amphioxus ER behaves as a dominant negative 
estrogen receptor in mammalian cells, even in the presence of BPA 
(Paris et al., 2008b), while SR transactivates in the presence of 
estrogens (Bridgham et al., 2008). Finally, the last group of receptors 
for which ligand-binding capacities have been studied is the NR1H 
subfamily (LXR and FXR). Amphioxus possesses 10 paralogues of 
the FXR/LXR (Farnesoid X Receptor/Liver X Receptor) subfamily 
due to a lineage-specific duplication event (Lecroisey et al., 2012, 
Schubert et al., 2008), with one of them being a clear orthologue of 
vertebrate LXR. Phylogenetic approaches only clarified the orthol-
ogy of 5 of the other receptors with vertebrate FXRs (Fonseca et 
al., 2017). Ligand binding has been characterized using transient 
transactivation assays for the amphioxus LXR with four different 
ligands (the synthetic molecule T0901317, and the natural ligands 
24(S)-hydroxycholesterol, 25-hydroxycholesterol and 24(S),25-
epoxycholesterol). While the amphioxus LXR is able to bind and 
transactivate a reporter gene in the presence of these ligands, it 
shows a low binding affinity for them compared with its vertebrate 
orthologues (Fonseca et al., 2017).
Receptor tyrosine kinase pathway
How does it work?
Receptor Tyrosine Kinases (RTKs) consist of a superfamily of 
transmembrane proteins presenting a variety of extracellular do-
main combinations and a tyrosine kinase cytoplasmic domain. The 
RTKs are receptors for several growth factors, as well as for some 
cytokines and hormones. The interaction between the receptors 
and their ligands usually induces a stabilization of a dimer of recep-
tors that can transphosphorylate each other on tyrosine residues 
present in the intracellular domain (Lemmon and Schlessinger, 
2010) (Fig. 5). This phosphorylation then allows interaction with 
several proteins that in turn are able to activate different cytoplasmic 
signalling cascades such as the MAPK (mitogen activated protein 
kinase) pathway, the PLCg (Phospholipase C-g) pathway or the 
PI3K (phosphatidylinositide 3-kinase) pathway (Fig. 5). 
The analysis of RTK gene content in amphioxus showed that 
it possesses at least one member of each of the subfamilies that 
are widespread in bilaterians (19 families) (D’Aniello et al., 2008). 
Amphioxus has generally one member of each of these subfamilies, 
but also some lineage-specific duplications, giving rise to 22 genes 
coding for proteins of the NOK family, 8 genes that are related to 
MET and AXL families, and 47 genes coding for receptors related 
to TIE, PD/VEGFR, RET, and FGFR families, which were named 
EXTKs (D’Aniello et al., 2008). However, analyses of gene expres-
sion have only been undertaken for a few of the receptors or their 
ligands. We will detail below expression and functional data for 
these specific RTKs.
Erythropoietin-producing human hepatocellular receptors
The EPH (erythropoietin-producing human hepatocellular recep-
tors) gene family can be separated into two groups in vertebrates: 
the EPHA group, which contains up to 10 members; and the EPHB 
group, with 6 members. In amphioxus, two genes, EPH1 and 
EPH2, resulting from a specific duplication in the cephalochordate 
lineage, were discovered in the B. floridae genome (D’Aniello et 
al., 2008, Mellott and Burke, 2008). They are both ohnologous to 
all the EPH genes from vertebrates, and they code for receptors 
with an EPH ligand binding domain, a TNFR (Tumor Necrosis 
Factor Receptor) domain, and two fibronectin III domains in the 
extracellular region (D’Aniello et al., 2008). In B. lanceolatum, 
EPH1 is expressed in the blastopore of gastrula stage embryos 
(Bosne, 2010). During neurulation, expression is detected in the 
cerebral vesicle and in the paraxial mesoderm. At the late neurula 
stage, before the mouth opens, EPH1 transcripts are detected in 
the anterior and posterior notochord, in the somites, the neural 
tube and in the pharyngeal endoderm. In the larva, expression is 
observed in the anterior and posterior notochord, in the cerebral 
vesicle as well as in the mouth, the club-shaped gland, the endo-
style and the pre-oral pit. The other receptor gene, EPH2, shows 
ubiquitous expression until the late neurula stage (Bosne, 2010). 
Prior to mouth opening, expression is stronger in the pharyngeal 
endoderm and in anterior and posterior notochord. In the larva, 
EPH2 transcripts are detected in the mouth and in the pharynx.
Ephrins (Eph receptor-interacting proteins), the ligands for 
EPHs, are membrane-bound proteins, implying that activation of 
the EPH signalling pathway is only possible through direct cell-
cell interaction. Two families of ligands are known in vertebrates, 
the EfnA and the EfnB groups. In amphioxus, there are three Efn 
genes (Efn1, 2 and 3) that result from a lineage-specific duplica-
tion in cephalochordates (Bosne, 2010). It is, up to now, not clear 
whether they are more closely related to EfnA or EfnB groups from 
vertebrates, although it has been proposed that group A may only 
be present in Olfactores (the clade containing vertebrates and 
urochordates) (Mellott and Burke, 2008). The expression patterns 
of Efn1 and Efn2 have been described in B. lanceolatum (Bosne, 
2010). Efn1 is expressed in the mesendoderm of the blastopore 
region of gastrulating embryos. At the neurula stage, expression 
is observed in the paraxial mesoderm and in some neurons in a 
segmented manner. At the late neurula stage, before mouth open-
ing, Efn1 transcripts are detected in the pharynx, in the posterior 
presumptive gut and in the tailbud. In the larva, expression is 
restricted to the mouth, the pharynx and the cerebral vesicle. At 
the gastrula stage Efn2 is ubiquitously expressed, and in neu-
rulae expression is widespread in the mesendoderm, although 
not in the most posterior region. Before the mouth opens, Efn2 
transcripts are observed in the ventral pharyngeal endoderm, in 
the presumptive endostyle region and in the posterior part of the 
future gut. In larvae, Efn2 is expressed mainly in the pharynx. No 
functional data on the role of the EPH signalling pathway during 
amphioxus embryogenesis have been described so far.
Fibroblast growth factor receptor
Amphioxus has a unique FGFR (Fibroblast Growth Factor 
Receptor) gene, coding for a receptor with three Immunoglobu-
lin extracellular domains, similarly to the four receptors found 
in vertebrates (D’Aniello et al., 2008, Suga et al., 1999). During 
embryogenesis, FGFR is first expressed at the gastrula stage in 
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the anterior mesendoderm (Bertrand et al., 2011). During neuru-
lation, expression is detected in the presomitic mesoderm and 
later on in presumptive notochord and somitic regions. At the 
late neurula stage, before the mouth opens, FGFR is expressed 
in the notochord, the anterior endoderm and the somites forming 
from the tailbud. In the larva, labelling is detected in the anterior 
pharyngeal endoderm, in the notochord, and at a lower level in 
the gut, except in the ilio-colonic region (Bertrand et al., 2011). 
FGFs are small proteins that are usually secreted. Eight FGF 
genes have been found in the B. floridae genome, but the orthol-
ogy relationships with vertebrate FGFs are well supported using 
phylogenetic reconstruction for only three of them, namely FGF1/2, 
FGF8/17/18 and FGF9/16/20 (Bertrand et al., 2011). However, 
synteny conservation analyses suggests that FGFA belongs to the 
FGF3/7/10/22 paralogy group, FGFB to the FGF4/5/6 group and 
FGFC to the FGF19/21/23 group. In contrast, no orthology relation-
ships with vertebrate FGFs could be proposed for FGFD and FGFE. 
Here we will keep this nomenclature of amphioxus FGFs even if 
other studies suggested different orthology relationships for some 
of the 8 amphioxus FGFs (Oulion et al., 2012). The expression of 
these ligands is very diverse and dynamic (Bertrand et al., 2011). 
FGF1/2 is ubiquitously expressed during embryogenesis, whereas 
FGFB and FGFD expression could not be detected using in situ 
hybridization. FGF8/17/18  and FGF9/16/20 are the first FGFs to 
show a regionalized expression at the gastrula stage. They are 
expressed complementarily in the dorsal part of the gastrula with 
FGF9/16/20 labelling being observed in the presumptive neural 
plate and FGF8/17/18  being expressed in the dorsal mesendo-
derm. At the neurula stage, expression of FGF8/17/18 completely 
fades in the mesendoderm and appears in the future cerebral 
vesicle, whereas FGF9/16/20 is expressed in the neural tube 
and in the pharyngeal endoderm. At this stage FGFA expression 
starts in the cerebral vesicle and in the pharyngeal endoderm as 
well as in the mesoderm with an antero-posterior gradient. Later 
on, FGF8/17/18 expression disappears in the cerebral vesicle and 
is observed in the most anterior tip of the epidermis, and in two 
regions of the pharyngeal endoderm corresponding to the future 
mouth and first gill slit territories in B. lanceolatum and B. floridae 
(Bertrand et al., 2011, Meulemans and Bronner-Fraser, 2007). 
This pattern is observed until the larva stage. At the late neurula 
stage FGF9/16/20 is expressed in a broad region of the ventral 
pharyngeal endoderm as well as in the neural tube and, in the 
larva, labelling is detected in the club-shaped gland, the first gill 
slit, the midgut as well as in the anus. FGFA is expressed in the 
cerebral vesicle and anterior ventral pharyngeal endoderm during 
late neurula stages, and in the endostyle, the club-shaped gland, 
the first gill slit, the mouth and the anus in larvae. FGFE expression 
starts in mid-neurula stage embryos in the Hatschek’s nephridium 
anlage. Later on, expression is observed in some neurons and, 
in the larva, FGFE expression is restricted to several neural tube 
neurons, to the club-shaped gland and to the gut, except the ilio-
colonic region. FGFC expression starts at the late neurula stage 
before the mouth opens in the most anterior endoderm and in 
the future gut just posterior to the pharyngeal region. In the larva, 
FGFC is expressed in the pre-oral pit, the endostyle and in the 
club-shaped gland.
FGF signalling function was assessed using pharmacological 
treatments with an inhibitor of FGFR (SU5402) at different time 
points (Bertrand et al., 2011). Inhibiting this pathway before gas-
trulation induces the loss of the most anterior somites, whereas 
the posterior ones form normally. Treatment after the gastrula 
stage leads to a milder phenotype and all the somites form, al-
though the correct morphogenesis of the notochord is affected. 
The function of FGF signalling at these stages is likely mediated 
by the MAPK pathway, as treatments with the MEK1/2 inhibitor 
U0126 induce the same phenotypes (Bertrand et al., 2011). On 
the other hand, when embryos are treated at the 8-cell stage with 
SU5402, gastrulation is strongly affected, while treatment with 
U0126 has no effect. This result suggests that the early function 
of the FGF signalling pathway is mediated by the activation of a 
cytoplasmic cascade that does not involve MAPK. Interestingly, it 
was shown that FGF signalling does not interact with the retinoic 
acid pathway during somitogenesis, in contrast to what is known 
in vertebrates (Bertrand et al., 2015).
Insulin receptor
Three receptors of the INSR (insulin receptor) subfamily are 
known in vertebrates: IGF1R (insulin-like growth factor 1 recep-
tor), INSR (insulin receptor) and INSRR (insulin receptor-related 
receptor) (Brunet et al., 2016). These receptors are characterized 
by the presence in their ectodomain of two L-domains separated 
by a furin-like cysteine rich region and followed by three fibronectin 
type III domains (Adams et al., 2000). Their ligands are the insulin 
and insulin-like growth factors (IGF) 1 and 2, which are secreted 
proteins of the insulin-relaxin family that are characterized by the 
presence of a cystine knot motif (Jin Chan and Steiner, 2000).
In amphioxus, a unique receptor presenting the classical domain 
organization detailed above has been described (D’Aniello et al., 
2008, Pashmforoush et al., 1996). The expression of INSR has 
so far only been assessed by Northern blot in B. californiensis 
adults transversally cut into four parts (Pashmforoush et al., 1996). 
The authors showed that transcripts could be detected in all of 
these four regions.
Two genes, coding for Insulin-like peptides (ILP) were described 
in the genome of B. floridae (Lecroisey et al., 2015) long after the 
first description of an Ilp gene in B. californiensis (Chan et al., 1990). 
Both are ohnologues of vertebrate insulin genes IGF1 and IGF2. 
The embryonic expression pattern of one of them, Ilp, was studied 
in B. lanceolatum (Lecroisey et al., 2015) and in neurulae of B. 
floridae (Holland et al., 1997). The authors showed that expression 
starts at the gastrula stage in the dorsal paraxial mesendoderm. 
Then, at the beginning of neurulation, Ilp is expressed in the most 
anterior forming somites and in the posterior endoderm, with a 
pattern reminiscent of the one observed for Delta at this stage. 
Expression then becomes restricted to the central endoderm in 
both species (Holland et al., 1997, Lecroisey et al., 2015). In late 
larvae prior to mouth opening, Ilp transcripts are detected in the 
dorsal pharyngeal endoderm and in the future gut, just posterior 
to the pharyngeal region. Finally, in larvae, Ilp is expressed in the 
pharyngeal anterior endoderm and in the club-shaped gland. In 
adults, Ilp (also known as IGF) is expressed in the hindgut and in 
the hepatic caecum (Guo et al., 2009).
There are no functional data concerning the role of the INSR 
signalling pathway during embryogenesis. However, the mode of 
action of INSR and its interaction with ILP or vertebrate ligands has 
been assessed by several laboratories in vitro or in mammalian 
cells (Guo et al., 2009, Liu and Zhang, 2011, Pashmforoush et 
al., 1996).
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Platelet-derived- and vascular endothelial- growth factor 
receptors
In vertebrates, there are five receptors of the PDGFR (Platelet-
Derived Growth Factor Receptor) family, and three of the VEGFR 
(Vascular Endothelial Growth Factor Receptor) family. Amphioxus 
possesses a unique receptor related to these two groups of RTKs, 
named PD/VEGFR. Phylogenetic and synteny conservation 
analyses suggest that the ancestral VEGFR and PDGFR found in 
vertebrates arose by tandem duplication of a unique PD/VEGFR 
gene before the two rounds of whole genome duplication (D’Aniello 
et al., 2008). The amphioxus PD/VEGFR protein shows a domain 
organization similar to vertebrate VEGFR receptors with seven 
extracellular immunoglobulin domains (D’Aniello et al., 2008, 
Suga et al., 1999). During embryonic development, PD/VEGFR 
is first expressed at the neurula stage in two populations of cells 
of mesodermal origin on both sides of the embryo in the anterior 
region (Pascual-Anaya et al., 2013). The cells on the left side were 
proposed to belong to the Hatschek’s nephridium anlage, which 
will form the excretory organ of amphioxus. Before the mouth 
opens, PD/VEGFR expression is still detected in the forming 
Hatschek’s nephridium as well as in single cells on the right side 
of the embryo (Pascual-Anaya et al., 2013). At the larval stage, 
PD/VEGFR expression is detected in lateral cells located between 
the notochord and the gut and below the somites. Labelling is also 
observed in the anlagen of both the two dorsal aorta branches and 
the subintestinal vessels, and in the club-shaped gland (Pascual-
Anaya et al., 2013). There are currently no data on genes coding 
for putative ligands of the amphioxus PD/VEGFR. The embryonic 
function of the PD/VEGFR signalling pathway was assessed us-
ing an inhibitor of the receptor (SU5416) (Pascual-Anaya et al., 
2013). Continuous treatment starting at the neurula stage induces 
a mild but penetrant phenotype with late neurula embryos and 
larvae presenting a curved posterior region (Pascual-Anaya et al., 
2013). The authors showed that this phenotype is associated with 
a reduction in Laminin immunostaining in the regions of the dorsal 
aorta and subintestinal vessels, suggesting that the PD/VEGFR 
pathway is implicated in the formation of the circulatory system in 
amphioxus (Pascual-Anaya et al., 2013).
Tropomyosin receptor kinase
Trk (tropomyosin receptor kinase) family members are neuro-
trophin receptors implicated in neuronal development, plasticity 
and survival (Lu et al., 2005). Amphioxus possesses a unique 
receptor ohnologue of vertebrate NTRK1, NTRK2 and NTRK3, 
and the protein presents a comparable domain organization to 
its vertebrate counterparts with cysteine-rich clusters, several 
leucine-rich repeats, and two IgC2 domains in its extracellular 
region (Benito-Gutierrez et al., 2005). Expression of B. floridae Trk 
is first observed in several epidermal cells in the ventral midline 
at the early neurula stage. Subsequently, labelling is detected in 
additional cells located mediolaterally. It has been proposed that 
these cells may be epidermal sensory neurons of the peripheral 
nervous system that migrate during embryonic development. At 
the larva stage, Trk expression is detected in the pre-oral pit and 
transiently in some anterior cells. 
Trk receptors have several ligands in vertebrates, including 
NGF (Nerve Growth Factor), BDNF (Brain-derived neurotrophic 
factor), NT-3 (Neurotrophin-3) and NT-4 (Neurotrophin-4), which 
are secreted proteins. A unique ligand gene has been found 
in amphioxus (Hallbook et al., 2006) but there is currently no 
information on its expression pattern. Interestingly, it has been 
shown that the amphioxus Trk receptor is activated by vertebrate 
neurotrophins and drives phosphorylation of both Akt and ERK1/2 
in mammalian cells (Benito-Gutierrez et al., 2005). However, the 
cephalochordate Trk is not able to induce PLCg phosphorylation 
after NGF stimulation in the same context, highlighting possible 
differences with the vertebrate neurotrophin pathway mode of ac-
tion (Benito-Gutierrez et al., 2005).
Other actors
Amphioxus possesses at least one member of each of the 
gene families coding for proteins implicated in the three main 
cascades activated by RTK, namely the MAPK, the PLCg and the 
PI3K pathways (Bertrand et al., 2009). The embryonic expres-
sion patterns of two genes from each cascade have so far been 
assessed in B. lanceolatum (Bertrand et al., 2009). H/K/NRASa, 
coding for a RAS GTPase implicated in the MAPK cascade, is 
expressed ubiquitously during early development (Bertrand et al., 
2009). Expression then becomes restricted to the notochord and 
the club-shaped gland anlage. In the larva, expression is detected 
in the posterior tip of the notochord and in the club-shaped gland. 
RAF, which codes for a MAPKKK, shows a ubiquitous expression 
pattern at early developmental stages (Bertrand et al., 2009). Later 
on, expression is observed in the whole mesoderm and endoderm 
as well as in the cerebral vesicle before the mouth opens. In the 
larva, similar expression is observed with high levels in the club-
shaped gland. PDK and AKT, coding for proteins of the PI3K 
cascade, are ubiquitously expressed, except in the epidermis, at 
almost all developmental stages (Bertrand et al., 2009). Within 
the PLCg cascade, PKCa/b/g is expressed ubiquitously at early 
stages (Bertrand et al., 2009). During neurulation, expression 
becomes restricted to ventral neurons of the cerebral vesicle and 
neural tube. In the larva, neural expression is still observed and 
PKCa/b/g  transcripts are also detected in the gut, except in the 
ilio-colonic region, in the club-shaped gland and in the pre-oral pit. 
Finally, PKCg expression is ubiquitous, although stronger expres-
sion is evident at the larva stage in the club-shaped gland and in 
the gut, again with the exception of the ilio-colonic region (Bertrand 
et al., 2009). Altogether, these data suggest that RTKs are able 
to activate only some specific intracellular cascades in particular 
embryonic regions in which the adequate actors are expressed at 
a given stage during amphioxus development.
Transforming growth factor b pathway
How does it work?
The TGF-b (Transforming Growth Factor b) signalling pathway 
plays crucial roles during embryogenesis as well as in cellular 
processes in adult animals (Derynck and Akhurst, 2007, Kishigami 
and Mishina, 2005, Massague et al., 2000). TGF-b family members 
are generally secreted and are cleaved into their active form, which 
contains a cystine knot (Weiss and Attisano, 2012). They bind to 
heterodimeric complexes composed of homodimers of type I and 
type II serine/threonine kinase transmembrane receptors. Fixation 
of the ligand induces the phosphorylation of the type I receptors 
by the type II receptors (Fig. 6). This phosphorylation results in the 
activation of the type I receptors, which subsequently phosphory-
late intracellular molecules called Smads (the name is a contrac-
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tion of Sma and Mad (Mothers against decapentaplegic)), which 
transduce the signal to the nucleus to regulate the transcription of 
target genes (Weiss and Attisano, 2012) (Fig. 6). Two signalling 
pathways are distinguished based on which Smad proteins are 
phophorylated by the activated transmembrane receptors after 
ligand binding: the BMP (Bone Morphogenetic Protein) signalling 
pathway, which is mediated by Smad1, -5 and -8; and the TGF-b/
Nodal/Activin signalling pathway, which utilises Smad2 and 3 in 
vertebrates (Bragdon et al., 2011, Chin et al., 2004, Massague et 
al., 2000). Interestingly, besides Smad signalling, it is now well 
established that other cascades are also activated downstream 
of TGF-b receptors, such as the MAPK cascade, the Rho-like 
GTPase signalling pathway and the PI3K pathway, indicating 
that both Smad and non-Smad signalling participate in the final 
outcome of the cellular response to TGF-b proteins (Bragdon et 
al., 2011, Zhang, 2009).
In addition to the diversity of TGF-b ligands and receptors, both 
BMP and TGF-b signalling pathways are regulated at the extracel-
lular level by a cocktail of proteins, including pseudoreceptors and 
extracellular inhibitors as well as metalloproteinases (Bier and De 
Robertis, 2015). Pseudoreceptors can interact with TGF-b recep-
tors and prevent the formation of active ligand/receptor complexes, 
whereas extracellular antagonists are able to bind to the ligands 
and decrease their affinity for their receptors (Balemans and Van 
Hul, 2002, Chin et al., 2004, Gazzerro and Canalis, 2006). Here 
we will focus our attention on extracellular regulation of TGF-b 
signalling in amphioxus. 
Receptors and extracellular actors in amphioxus
In the B. floridae genome, three type I (Alk1/2, Alk3/6 and 
Alk4/5/7) and three type II (TGF-bRII, ActRII and BMPRII) receptor 
genes have been identified (Satou et al., 2008), but no expres-
sion pattern has been reported yet. However, the expression of 
the pseudoreceptor BAMBI (BMP and Activin Membrane-Bound 
Inhibitor) has been analyzed during early developmental stages. 
BAMBI transcripts are detected at the gastrula stage in the ventral 
mesendoderm and, later on during neurulation, in the endoderm 
(Yu et al., 2007).
Eighteen TGF-b genes are present in the B. floridae genome 
(Satou et al., 2008). Among these extracellular ligands, the orthol-
ogy relationships with vertebrate TGF-b family members have been 
clearly defined by phylogenetic analysis for thirteen of them (Satou 
et al., 2008). Six genes coding for ligands of the BMP subfamily 
were identified as ADMP, BMP2/4, BMP3/3b, BMP5-8, BMP9/10 
and GDF5/6/7, and seven of the TGF-b/Nodal/Activin subfamily, 
namely Lefty, Myostatin, Nodal, TGF-b, Vg1, and two Activin/Inhibin 
genes (Satou et al., 2008). Developmental expression patterns 
have been described in amphioxus for ADMP (Kozmikova et al., 
2013, Yu et al., 2007), BMP2/4 (Kozmikova et al., 2013, Panopou-
lou et al., 1998, Yong et al., 2017, Yu et al., 2007), BMP3/3b (Sun 
et al., 2010), BMP5-8 (Kozmikova et al., 2013, Yu et al., 2007), 
Lefty (Morov et al., 2016, Onai et al., 2010, Yu et al., 2007), Nodal 
(Morov et al., 2016, Onai et al., 2010, Yu et al., 2002, Yu et al., 
2007) and Vg1 (Onai et al., 2010).
ADMP is first expressed in the dorsal half of the mesendoderm 
from the early gastrula stage until the end of gastrulation in B. 
floridae. At the mid-gastrula stage, ADMP starts to be expressed 
in the neural plate; this expression is maintained until the neurula 
stage, when transcript detection becomes restricted to the medial 
part of the plate. At this stage, paraxial mesoderm expression of 
ADMP is progressively lost but is maintained in the axial mesoderm 
(Kozmikova et al., 2013, Yu et al., 2007).
From the onset of gastrulation, BMP2/4 and BMP5-8 are co-
expressed in the entire mesendoderm until the late gastrula stage, 
when their expression in the axial mesoderm begins to disappear, 
concomitantly with the appearance of expression of BMP2/4 in 
lateral and ventral ectoderm (Kozmikova et al., 2013, Panopoulou 
et al., 1998, Yu et al., 2007). BMP2/4 expression is then lost in the 
Fig. 6. Simplified schematic view 
of the canonical transforming 
growth factor (TGF)-b signalling 
pathway. The binding of ligands 
to a dimer of type II receptors 
leads to their phosphorylation. In 
turn, this dimer interacts with, and 
phosphorylates, a dimer of type I 
receptors. Activated type I dimers 
phosphorylate a regulatory SMAD 
(R-SMAD), which interacts with 
SMAD4. The dimer enters the nu-
cleus and activates the transcription 
of target genes after DNA binding.
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somites during neurulation, except in the tailbud. Expression is also 
observed in some epidermal cells in front of the neuropore. Within 
the endodermal derivatives, BMP2/4 is expressed in the pharyn-
geal region and in the posterior presumptive gut; no expression 
is detected in the midgut from the neurula stage onwards. At the 
late neurula stage, BMP2/4 transcripts are detected in the form-
ing club-shaped gland and in the Hatschek’s right diverticulum as 
well as in a row of mesothelial cells on the right along the “ventral 
midline”. In the larva, BMP2/4 expression pattern is quite similar 
(Panopoulou et al., 1998). No expression data are available for 
BMP5-8 after the early neurula stage.
BMP3/3b is expressed during gastrulation in the whole mesen-
doderm of B. japonicum. At the neurula stage, BMP3/3b is first 
expressed in the border of the neural plate and in the paraxial 
mesoderm. Later on, expression is detected in part of the neural 
plate and in median somites. At the larva stage, BMP3/3b is ex-
pressed in the anterior part of the closed neural tube, in the phar-
ynx, the Hatschek’s left diverticulum, the pre-oral ciliated pit, the 
club-shaped gland and the gill slits (Sun et al., 2010). Expression 
of BMP3/3b has also been reported in adult amphioxus, where the 
BMP3/3b transcripts are detected in the nerve cord, the sheath 
surrounding the notochord, the metapleural fold and in the oocytes 
(Sun et al., 2010).
Nodal, Vg1 and Lefty possess very similar expression pattern 
during embryonic development in amphioxus. Both Nodal and Vg1 
are expressed maternally. Vg1 is expressed ubiquitously until the 
end of the blastula stage, whereas Nodal expression is restricted 
to the two-thirds of the embryo towards the animal pole. During 
gastrulation, Nodal, Vg1 and Lefty are expressed in the dorsal 
ectoderm and mesendoderm, with Lefty expressed in a more 
axially restricted region (Morov et al., 2016, Onai et al., 2010, Yu 
et al., 2002, Yu et al., 2007). At the neurula stage, these three 
genes begin to be expressed only on the left part of the embryo, 
first in the three most anterior somites and later on in all of the left 
somites, with stronger expression in the most anterior somites and 
the posterior forming somites (Onai et al., 2010, Yu et al., 2002, 
Yu et al., 2007). Nodal is also expressed in the Hatschek’s left 
diverticulum, the lateral ectoderm and endoderm corresponding 
to the future region where the mouth will open at the late neurula 
stage (Yu et al., 2002). More detailed expression patterns for Vg1 
and Lefty are not available after neurula stage. At the larval stage, 
Nodal expression is restricted to the most posterior part of the 
left somitic tissue, expression which disappears in one week old 
larvae (Yu et al., 2002).
Other actors
In amphioxus, seven extracellular proteins orthologous to pro-
teins known to exert an antagonist or modulator activity on BMP 
or TGF-b/Nodal/Activin ligands have been identified: Cerberus, 
Chordin, Gremlin, and NBL1 (Neuroblastoma suppressor of tumori-
genicity 1, also called DAN), Noggin, Tsg (Twisted gastrulation) and 
Tolloid (also called Xolloid in Xenopus and BMP1 in human). The 
expression pattern has been described for all the corresponding 
genes except Noggin. 
Cerberus, Gremlin and NBL1 belong to the DAN (Differential 
screening-selected gene Aberrative in Neuroblastoma) family and 
present a typical cystine knot structure. Cerberus is first expressed 
at the gastrula stage in the anterior mesendoderm underlying the 
presumptive neural plate. At the early neurula stage, Cerberus 
expression is observed in the first anterior somites before becoming 
asymmetrical after the loss of expression on the left side. At the 
mid-neurula stage, Cerberus is no longer expressed in the somites 
and transcripts are only detected in the ventral part of the closing 
neural tube. No expression could be detected by in situ hybrid-
ization at later stages (Le Petillon et al., 2013, Onai et al., 2010).
Gremlin is first expressed in a small, restricted region of the 
ventral mesendoderm, expression which remains at the early 
neurula stage when Gremlin also begins to be expressed in cells 
along the borders of the neural plate. At the mid-neurula stage, 
Gremlin is expressed in cells lateral to the neural tube and at the 
level of the midline of the ventral endoderm. Gremlin expression is 
also detected at the level of the first left somite in the presumptive 
Hatschek’s nephridium. At the late neurula stage these territories 
still express Gremlin, which begins to be expressed in the cerebral 
vesicle. At the larval stage, Gremlin is expressed in some cells of 
the cerebral vesicle and in cells of the pre-oral pit and endostyle 
(Le Petillon et al., 2013).
In amphioxus, NBL1 expression has only been detected at 
the larval stage in the somites and in the club-shaped gland (Le 
Petillon et al., 2013).
Chordin is one of the first BMP modulator proteins to have been 
characterized in amphioxus. Interestingly, expression of Chordin 
is similar to the expression of ADMP in amphioxus. Chordin is 
first expressed in the dorsal ectoderm and mesendoderm during 
gastrulation. At the neurula stage, expression is observed in the 
neural plate and in the axial and paraxial mesoderm before being 
restricted to the medial part of the closing neural plate and to the 
axial mesoderm (Somorjai et al., 2008, Yu et al., 2007). Then, before 
mouth opening, Chordin is expressed in the posterior region of the 
embryo and in particular neurons. Finally, in the larva, Chordin is 
expressed in the posterior region, in the club-shaped gland, and 
in the cerebral vesicle (Somorjai et al., 2008).
Tsg and Tolloid are two proteins known to modulate BMP signal-
ling (Troilo et al., 2016). Tolloid is a zinc metalloproteinase able to 
cleave Chordin, making it unable to antagonize BMP ligands. Tsg 
is able to bind either BMP or the BMP/Chordin complex, thereby 
having antagonistic or agonistic activity. It can also enhance Tol-
loid cleavage activity on Chordin, decreasing its anti-BMP action. 
In amphioxus, Tsg begins to be expressed at the early gastrula 
stage in the dorsal mesendoderm and is expressed during neurula 
stage in the whole mesoderm (Yu et al., 2007). Tolloid-like is first 
expressed at the mid-gastrula stage in the ventral mesendoderm and 
then in the ventral endoderm during neurulation (Yu et al., 2007).
Functional studies
The main strategy used to modify TGF-b signalling during 
amphioxus development is the use of small molecule inhibitors 
and recombinant proteins to inhibit or activate TGF-b pathways, 
respectively. Dorsomorphin is used to inhibit BMP type I receptor 
(Alk3/6) and has been shown to disrupt the nuclear localization 
of phosphorylated Smad1/5/8 (Kaji et al., 2016, Kozmikova et al., 
2013, Lu et al., 2012). SB505124 and SB431542 are two inhibi-
tors of TGF-b type I receptors (Alk4/5/7) used to inhibit TGF-b/
Nodal/Activin pathway (Bertrand et al., 2015, Kaji et al., 2016, 
Kozmikova et al., 2013, Li et al., 2017, Morov et al., 2016, Onai et 
al., 2010, Soukup et al., 2015). In contrast, recombinant proteins 
such as zBMP4 (Lu et al., 2012, Onai et al., 2010, Yu et al., 2008, 
Yu et al., 2007), hBMP2 (Kozmikova et al., 2013), hActivin (Onai 
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et al., 2010) and mNodal (Li et al., 2017) (h=human, m=mouse, 
z=zebrafish) have been used to activate TGF-b pathways in am-
phioxus. Due to the technical difficulties involved in microinjecting 
amphioxus eggs, the use of other tools is still scarce. Nevertheless, 
injections of mRNA, morpholinos, plasmids or TALENs have also 
been used to assess the embryonic function of TGF-b pathways, 
as detailed below.
It was first shown using pharmacological treatments that ectopic 
BMP activation induces the ventralization of the amphioxus embryo, 
with a loss of expression of dorsal genes and an expansion of ventral 
gene expression (Kozmikova et al., 2013, Onai et al., 2010, Yu et 
al., 2008, Yu et al., 2007). In contrast, inhibiting BMP signalling at 
the blastula stage induces a dorsalization of the embryo with an 
expansion of the expression of dorsal markers (Kozmikova et al., 
2013). On the other hand, earlier inhibition induces the dorsalization 
of the mesendoderm whereas the ectoderm stays in an uncommitted 
fate and expresses the pan-ectodermal gene SoxB1a but fails to 
express epidermal or neural markers. These results strongly sug-
gest that BMP signal inhibition is insufficient for neural induction 
in amphioxus, but that it is required for epidermal fate acquisition 
by ectodermal cells (Le Petillon et al., 2017).
Interestingly, the TGF-b/Nodal/Activin pathway appears to act 
in opposition to the BMP signal for axis formation during early de-
velopment. Indeed, activation of this pathway using recombinant 
hActivin treatment induces an expansion of dorsal ectodermal 
and mesodermal gene expression, and a loss of expression of 
ventral genes (Onai et al., 2010), whereas its repression before 
gastrulation induces the ventralization of the embryo (Morov et al., 
2016, Onai et al., 2010). Moreover, it has been shown that BMP 
and TGF-b/Nodal/Activin signals concomitantly control antero-
posterior patterning with an anteriorizing role for the TGF-b/Nodal/
Activin signal and a posteriorizing role for the BMP signal (Onai et 
al., 2010). The authors also analyzed the function of Chordin by 
injecting corresponding morpholinos. They showed that Chordin 
knock-down induces a mild phenotype with a loss of anterior marker 
expression, but to a lesser extent than when the BMP signal was 
ectopically activated, suggesting that other BMP antagonists might 
be playing a parallel role in inhibiting BMP signal in the dorsal part 
of the amphioxus embryo (Onai et al., 2010). In contrast, injection 
of Cerberus mRNA induces a ventralization and posteriorization 
similarly to BMP signal activation and the authors therefore suggest 
that Cerberus might be a TGF-b/Nodal/Activin signal antagonist 
in amphioxus (Onai et al., 2010). It was also recently shown 
that Nodal/Activin is playing a crucial role for neural induction in 
amphioxus independently of BMP signal inhibition and that the 
interactions between both pathways might be tightly regulated in 
time and space (Le Petillon et al., 2017).
In addition to the role of BMP during antero-posterior and dorso-
ventral patterning, it has been proposed that the BMP signal might 
be involved in the formation of epidermal sensory neurons (ESNs) 
in amphioxus, since manipulating BMP signalling levels affects the 
distribution of ESNs (Lu et al., 2012). Interestingly, as previously 
discussed, Delta/notch signalling is implicated in the specification 
of ESN, and Lu and colleagues showed that BMP signal functions 
upstream of Delta/Notch to induce/maintain in vivo a ventral neu-
rogenic domain from which the ESNs will derive (Lu et al., 2012). 
Based on comparative observations with vertebrates, the authors 
proposed that differences in BMP signal regulation could explain 
differences in peripheral nervous system formation in the different 
chordate lineages (Lu et al., 2012).
Nodal signalling is also involved in left/right axis establishment. 
Based on chemical inhibition of TGF-b type I receptors after gas-
trulation, Soukup and colleagues showed that after inhibition of 
the TGF-b/Nodal/Activin signalling pathway, the left-sided genes 
are mostly downregulated during early neurula stage and that their 
expression is later lost. On the other hand, the right-sided genes 
become symmetrically expressed after such inhibition (Soukup et 
al., 2015). Consequently, asymmetry of some structures like the 
pharynx, the somites and the associated neural system, is lost 
in embryos deprived of Nodal signalling, which present two right 
sides (Bertrand et al., 2015, Soukup et al., 2015). Recently, these 
observations were confirmed using transgenic lines of amphioxus 
with a mutated version of Cerberus, created using the TALEN 
technique, and using heat shock promoter driving overexpression 
of several actors of the Nodal pathway such as Cerberus, Nodal, 
Lefty and Pitx (Li et al., 2017).
A consequence of the loss of asymmetry due to Nodal signal 
inhibition is the absence of the mouth, which normally forms 
on the left side of the amphioxus embryo. Indeed, Kaji and col-
leagues observed that at the level of the left-most anterior somite, 
a mesovesicle they suggested to be crucial for mouth opening 
is absent from embryos depleted of Nodal signal after gastrula-
tion (Kaji et al., 2016). The same authors showed that inhibiting 
the BMP pathway using dorsomorphin impedes mouth opening, 
suggesting that both Nodal and BMP signals are crucial for this 
developmental process (Kaji et al., 2016). Conversely, deregula-
tion of endogenous Nodal activity in Cerberus mutants induces the 
formation of a mouth on both sides of the embryo (Li et al., 2017).
Wnt/b-catenin pathway
How does it work?
Wnt ligands are secreted glycoproteins mediating cell fate de-
cisions, proliferation, and cell movements during embryogenesis 
across metazoans (Loh et al., 2016). The first Wnt discovered in 
mouse, named int1 (integration 1) for its oncogenic role (Nusse 
and Varmus, 1982), was later shown to be homologous to the 
Wingless (Wg) segment polarity gene in Drosophila. In its simplest 
form, during b-catenin dependent or “canonical” signalling, Wnt 
proteins bind the Frizzled 7-transmembrane domain receptors at 
the membrane along with LRP5/6 (Low-density lipoprotein receptor-
related protein), thereby recruiting Dishevelled (Fig. 7) (Clevers, 
2006). This prevents the scaffolding proteins including APC (Ad-
enomatous polyposis coli) and Axin from assembling the b-catenin 
“destruction complex”, a large multi-protein assemblage including 
GSK3b (Glycogen synthase kinase 3b) and CK1 (Caseine kinase 
1) kinases; b-catenin is then able to accumulate in the cytoplasm, 
and free to enter the nucleus, binds TCF (T-cell factor) and other 
transcriptional partners such as Groucho to mediate downstream 
signalling events (Fig. 7) (Clevers, 2006). However, in the absence 
of Wnt ligand, b-catenin is targeted by the b-TrCP E3 ubiquitin ligase 
for ubiquitination, and is degraded by the proteasome (Baron and 
Kneissel, 2013). This is mediated by assembly of the destruction 
complex at b-catenin, and CK1a and GSK3b phosphorylation at 
key residues in its N-terminus (Clevers, 2006). In the absence 
of signalling, Axin may also undertake an alternate conformation 
that blocks its interaction with LRP5/6, but leaves it free to bind 
b-catenin to mediate its degradation (Song et al., 2014). 
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The Wnt/b-catenin pathway is also modulated by a number 
of co-receptors and extracellular antagonists, including secreted 
frizzled related proteins (sFRPs), Dickkopf (Dkk) proteins, and 
Kremens. sFRPs may antagonize signalling in a variety of ways, 
including via direct interaction with Wnt proteins through their CRD 
and Netrin domains, or through heterodimerization with Frizzleds, in 
each case effectively preventing Wnt/Frizzled coupling. Instances in 
which sFRPs promote pathway activation have also been reported, 
however, highlighting the importance of cellular context in mediating 
interactions between possible binding partners (Bovolenta et al., 
2008). Dkks in the Dkk1/2/4 class, in contrast, are thought to inhibit 
Wnt/b-catenin by binding directly to the ectodomains of LRP5/6, 
and thus interfering with Wnt ligand binding (Bao et al., 2012). 
Kremens are co-receptors for Dkks, and can also bind LRP5/6 in 
a ternary complex (Zebisch et al., 2016); interestingly, in the pres-
ence of Dkk, Kremen proteins enhance Wnt inhibition, while in the 
absence of Dkk they potentiate LRP5/6 mediated signalling, thus 
acting as a bi-modal switch during Wnt signalling. 
Alternative, “non-canonical” b-catenin-independent pathways 
have also been identified, but are poorly understood and much less 
well characterized in most systems. Some are mediated by Wnt 
ligands, Frizzled receptors and Dishevelled at the membrane, in 
addition to other G-protein coupled receptors. Indeed, Dishevelled 
has been considered to be a branching point between b-catenin 
dependent and independent pathways (Gao and Chen, 2010), and 
it is becoming apparent that such cross-functionality is common 
(Angers and Moon, 2009). Others utilize alternative receptors, 
including receptor tyrosine kinases such as ROR or RYK, and do 
not act positively on b-catenin mediated transcription in the nucleus, 
but rather on the actin cytoskeleton, calcium signaling or other 
nuclear targets (Van Amerongen, 2012). These are collectively 
known as “Wnt polarity” pathways due to their roles in cellular 
behavior such as convergence extension or axon guidance (Loh 
et al., 2016). Given our still limited understanding of how these dif-
ferent pathways are structured, particularly in amphioxus, we focus 
on a review of members in the context of Wnt/b-catenin signalling, 
with the caveat that many of the upstream components (ligands, 
receptors etc) described here may be functionally involved in more 
than one Wnt pathway.
Receptors and ligands in amphioxus
Wnt ligands are characterized by an N-terminal signal peptide, 
and C-terminal cysteine residues responsible for the physical inter-
action with Frizzled receptors. In amphioxus, 12 Wnt genes have 
been identified corresponding to each of the subfamilies thought 
to have been present in the bilaterian last common ancestor, with 
the exception of WntA (reviewed in Albalat and Canestro, 2016). 
In vertebrates, a number of Wnt duplicates have been retained fol-
lowing the 2 whole genome duplications in the vertebrate ancestor 
within these subfamilies. Eight amphioxus Wnt ligands were first 
characterized in B. floridae, including Wnt1, -3, -4, -5, -6, -7, -8 and 
Wnt11 (Holland et al., 2000, Schubert et al., 2000a, Schubert et al., 
2000c, Schubert et al., 2000d, Schubert et al., 2001). Five of these 
have been partially characterized in B. lanceolatum (Wnt3-Wnt8), 
and one in B. japonicum (Wnt8); their expression shows broad 
conservation with that seen in the American species (Albuixech-
Crespo et al., 2017, Morov et al., 2016, Somorjai et al., 2008).
Wnt1 is first detected around the lip of the blastopore in gastrulae, 
and is the most posterior expressed ligand, with expression in the 
posterior wall of the neurenteric canal in late neurulae (Holland 
et al., 2000). Qian and colleagues also report that it is maternally 
expressed by RT-qPCR (Qian et al., 2013).
Wnt3 shows similar blastoporal expression in early gastrulae, 
but is expressed along the edges of the neural plate by the early 
Fig. 7. Simplified schematic view of the Wnt/b-catenin signalling pathway. In the absence of Wnt (OFF), b-catenin (b-cat) is phosphorylated by a 
multi-protein “destruction complex”, then ubiquitinated, and, finally, degraded by the proteasome. When a Wnt ligand binds to the receptor Frizzled along 
with LRP5/6 (ON), Dishevelled is recruited at the membrane. This prevents the formation of the “destruction complex”. b-catenin then accumulates in 
the cytoplasm and enters the nucleus, where it binds partners such as Tcf/Lef to mediate transcriptional activation of target genes.
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neurula stage except most anteriorly (Schubert et al., 2001). Similar 
expression is seen in mid-neurulae of B. floridae and B. lanceolatum 
(Albuixech-Crespo et al., 2017, Schubert et al., 2001).  As neurulation 
proceeds, this expression domain resolves to the posterior neural 
tube and ectoderm, and the posterior wall of the neurenteric canal. 
In early larvae, Wnt3 can also be detected in the cerebral vesicle, 
in addition to these domains (Schubert et al., 2001). 
In contrast to Wnt3, Wnt4 is expressed throughout the mesendo-
derm in gastrulae, but most strongly around the blastopore excluding 
the ectoderm (Schubert et al., 2000b). In neurulae, transcripts are 
detected in the posterior paraxial mesoderm and hindgut endoderm, 
but not in the nascent notochord or neural plate; later expression is 
most notable in the posterior at tailbud level, in the neural tube and 
cerebral vesicle. In larvae, expression persists in somites, neural 
tube, hindgut endoderm and posterior cerebral vesicle, in addition 
to appearing in endostylar endoderm and mesothelial cells near 
the forming second gill slit (Schubert et al., 2000b).
Wnt5 is expressed in the mesendoderm of the gastrula, but 
only and very conspicuously around the blastopore, more similarly 
to Wnt3 (Schubert et al., 2001). By early to mid-neurula stages, 
expression is strongest in posterior paraxial mesoderm and ventral 
endoderm in both American and European species (Albuixech-
Crespo et al., 2017, Schubert et al., 2001, Somorjai et al., 2008), 
clearly corresponding to the tailbud by premouth larval stages. Wnt5 
is also expressed in the cerebral vesicle and pharynx, resolving 
to the club-shaped gland in late larvae, as well as the anterior no-
tochord and nascent somite of the tailbud (Schubert et al., 2001).
Wnt6 is maternally expressed (Qian et al., 2013), and as with 
many other Wnt genes, Wnt6 is expressed around the blastopore 
in gastrulae. However, Wnt6 is most conspicuously expressed in 
the CNS in pairs of spots on either edge of the neural plate in early 
neurulae, as well as in posterior mesoderm (Schubert et al., 2001, 
Somorjai et al., 2008). In late neurulae, transcripts are detected 
in the last pair of forming somites, along the length of the neural 
tube but not in the cerebral vesicle, and in the posterior wall of 
the neurenteric canal; both the posterior-most neural tube and 
neurenteric canal expression domains persist in 7-day larvae in 
B. floridae (Schubert et al., 2001).
Wnt7 has so far not been detected in any stage prior to or in-
cluding the blastula. In gastrulae, Wnt7 is expressed throughout 
the mesendoderm, but by early neurula stages is almost entirely 
restricted to a small central region at the edges of the closing 
neural tube (Schubert et al., 2000b, Somorjai et al., 2008). In B. 
lanceolatum mid-neurulae, the anteriormost extension of Wnt7 
abuts the posterior boundary of the DiMes (Di-Mesencephalic 
primordium), thought to be equivalent to the vertebrate Midbrain/
Hindbrain boundary, similarly to Wnt3 (Albuixech-Crespo et al., 
2017).  As neurulation proceeds, transcripts are detected throughout 
the neural tube, with the exception of the most posterior parts, but 
including posterior parts of the cerebral vesicle (Schubert et al., 
2000b). In 90hpf B. floridae larvae, roughly the anterior two-third 
of the neural tube expresses Wnt7, and expression in the posterior 
cerebral vesicle persists, with a new domain appearing consisting 
of a few endodermal cells of the endostyle (Schubert et al., 2000b).
Wnt8 expression in amphioxus is highly dynamic, and is first 
detected in the early gastrula dorso-laterally in prospective par-
axial mesoderm on either side of the archenteron in B.floridae 
and B.japonicum (Morov et al., 2016, Schubert et al., 2000d). In 
early neurulae, posterior paraxial mesoderm is strongly labelled, 
later defining all somites except the first pair, and in a restricted 
posterior domain of the endoderm that will give rise to the hindgut. 
In late neurulae of both B. floridae and B. lanceolatum, transcript 
expression remains strongest in the posterior mesoderm and 
endoderm of the growth zone anterior to the tailbud and in sev-
eral anterior somites posterior to the first pair, but is reduced in 
intervening somites (Albuixech-Crespo et al., 2017, Schubert et 
al., 2000d). In 3-day B. floridae larvae, a subset of ventral cells in 
the cerebral vesicle continues to express Wnt8, but otherwise the 
gene is downregulated (Schubert et al., 2000d). 
In cephalochordates, Wnt11 has only been characterized in 
B. floridae and, besides being maternally expressed (Qian et al., 
2013), shows the earliest zygotic expression of the Wnt ligands, 
with expression in a few cells of the presumptive dorsal side in 
late blastulae beginning at gastrulation (Schubert et al., 2000a). In 
neurulae, Wnt11 is expressed in mesodermal myotomes as well as 
in posterior endodermal and ectodermal domains. By larval stages, 
most mesodermal expression is lost except in posterior somites, 
and transcripts can be detected in antero-ventral ectoderm, some 
ventral mesothelial cells and posterior ectoderm possibly giving 
rise to the tail fin (Schubert et al., 2000a).
Of the remaining ligands, expression data are still lacking for 
Wnt2, Wnt9, Wnt10 and Wnt16, but Wnt9 and Wnt10 at least are 
maternally expressed (Qian et al., 2013). Nothing is known about 
the role of any Wnt in later larval development, but Wnt5 is also 
expressed in the undifferentiated blastema during tail regeneration 
in adult B. lanceolatum (Somorjai et al., 2012a).
The Frizzled proteins are G-protein coupled receptors (GPCRs) 
containing a cysteine-rich domain (CRD). Four Frizzled receptors, 
Fz1/2/7, Fz4, Fz5/8 and Fz9/10, have been described in the Asian 
species B. belcheri (Qian et al., 2013), corresponding to the four 
subfamilies present in the bilaterian plus cnidarian common ances-
tor (Schenkelaars et al., 2015). The fifth, Fz3/6, appears to be an 
innovation of the Olfactores, most closely related to the Fz1/2/7 
clade (Schenkelaars et al., 2015). RT-qPCR suggests that all four 
Frizzled genes are expressed maternally and ubiquitously in the 
4-cell stage (Qian et al., 2013). In the early neurula Fz1/2/7 is 
expressed in the neural plate as well as in somites. The authors 
suggest that in the larva Fz1/2/7 is expressed in the mouth and 
the pre-oral pit. Early Fz1/2/7 domains partially overlap with those 
of Fz4. Fz4 is the only gene clearly expressed in the cerebral 
vesicle from mid-neurula to larval stages; otherwise it is broadly 
expressed in mesendoderm, as well as in the pre-oral pit and in 
components of the pharynx (Qian et al., 2013). Fz5/8 is distinc-
tive in maintaining expression from late gastrula to late larva in 
the anterior-most ectoderm and endoderm of the embryo (Qian et 
al., 2013). Finally Fz9/10 has the most posterior expression in the 
early neurula of all Frizzled genes analysed, showing expression 
in the posterior neural plate of the mid-neurula stage embryo, and 
in the last-formed somites (Qian et al., 2013). 
Inhibitors/antagonists
sFRPs are Frizzled Related Proteins that can be secreted due 
to the replacement of the transmembrane domains with a Netrin 
domain, and can compete with Frizzled for binding to Wnt ligands. 
Two have been identified in cephalochordates, and their expres-
sion patterns characterized in B. floridae (Yu et al., 2007) and B. 
belcheri (Kong et al., 2012), where they are broadly consistent. 
sFRP1/2/5, otherwise named sfrp2-like, is expressed in the 
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mesendoderm in gastrulating embryos, later becoming restricted 
to the anterior mesoderm and endoderm in neurula stages. Kong 
and colleagues further report that expression becomes undetect-
able from the late neurula stage onwards in B. belcheri (Kong et 
al., 2012). The second, sFRP3/4, has only been described for 
early stages in B. floridae, where like sFRP1/2/5 it is expressed 
in mesendoderm in mid-gastrulae. By late gastrula/early neurula, 
expression is restricted to a domain around the blastopore, and 
weakly in the mesoderm. 
The first Dickkopf protein, Dkk1, was described in Xenopus, 
where it was shown to be a potent antagonist of Wnt signalling, and 
to have head-inducing activity (Glinka et al., 1998). Two antagonists 
of the Dickkopf family have been described in cephalochordates, 
corresponding to the two paralogy groups found in vertebrates: 
Dkk1, -2 and -4 and Dkk3. While Dkk1 -2 and -4 show Wnt an-
tagonizing activity, the role of Dkk3 in Wnt signalling is unclear, but 
it may potentiate Wnt signalling in some contexts (Nakamura et 
al., 2007). In B. floridae, Dkk1/2/4 is expressed vegetally in early 
gastrulae, and most strongly in a mesendodermal ring around the 
blastopore (Yu et al., 2007). By neurula stages, it is expressed not 
only at the site of blastopore closure, but also in two clear anterior 
stripes on either side of the midline in the first two pairs of somites. 
This expression is similar in B. belcheri until mid-neurula stages, 
when the posterior domain further resolves into a pair of expression 
spots in what appear to represent the last formed somites (Zhang 
and Mao, 2010). Later, expression becomes asymmetric on the 
left side in tailbud mesoderm, where by premouth larval stages 
it has disappeared entirely. In larvae, Dkk1/2/4 is only expressed 
in two anterior left patches in the pharyngeal region, and finally 
only in the cerebral vesicle of late larvae (Zhang and Mao, 2010). 
In amphioxus, Dkk3 possesses an additional TGF-b receptor 2 
domain in the N-terminus, which is absent in other species (Onai et 
al., 2012). Dkk3 expression in B. floridae is virtually a mirror image 
of Dkk1/2/4 at early stages, when it is expressed most strongly in 
the animal pole, until resolving into a strong anterior ectodermal 
and an anterior-ventral endodermal domain in neurulae (Yu et al., 
2007). Careful sectioning shows that the expression of Dkk3 in the 
anterior endoderm is restricted to the left side, while that in the 
ectoderm is limited to the anterior end of the neural plate (Onai et 
al., 2012). Surprisingly, in B. belcheri Dkk3 expression has only 
been detected in a central patch of the larval gut (Zhang and Mao, 
2010), which is difficult to corroborate as data are absent in other 
cephalochordates for late stages. Taken together with dorsal/ven-
tral expression of BMP ligands and antagonists, the expression 
of Wnt antagonists such as Dkk1/2/4 and sFRPs anteriorly, along 
with multiple Wnt ligands posteriorly, suggested the existence of 
a dorsal organizer in amphioxus as found in vertebrates (Yu et 
al., 2007). The presence of such an organizer in amphioxus  has 
indeed recently been confirmed (Le Petillon et al., 2017).
Co-regulators 
In addition to the receptors and antagonists/inhibitors described 
above, the Wnt/b-catenin pathway is regulated by a number of 
co-receptors extracellularly, including low-density lipoprotein 
receptor-related proteins (LRP) and Kremen proteins, many of 
which act through binding Dkks with high affinity. In vertebrates, 
LRP5 and -6 are orthologous to the single LRP5/6 (“Arrow” in 
Drosophila) found in amphioxus. LRP5/6 expression has been 
described only in B. floridae, and perhaps unsurprisingly given its 
function, is expressed almost ubiquitously in the mesoderm and 
endoderm of neurula stage embryos, with the exception of the 
tailbud (Wang et al., 2016). 
In vertebrates, two Kremens have been identified, Kremen1 
and Kremen2, with clear roles in potentiating the Wnt inhibitory 
effects of Dkk1 (Cruciat and Niehrs, 2013) via direct binding in a 
ternary complex with LRP6 (Zebisch et al., 2016). In the B. floridae 
genome, four Kremen genes (Krm1, -2, -3, -4) with close affinity 
and similar domain structure content to vertebrate Kremens 1 and 
-2 have been localized to the same scaffold, and thus appear to 
have evolved via tandem duplication (Zhang and Mao, 2010). The 
authors further identify at least three additional Kremen-like (Krl) 
proteins, all with alternate domain structures lacking the Kringle 
domain (Zhang and Mao, 2010). Developmental expression of B. 
belcheri Krm1 and Krm2 has been described (Zhang and Mao, 
2010). Krm1 is reportedly expressed throughout the mesendoderm 
and axial somitic and notochordal mesoderm and dorsal endoderm 
in neurulae and larvae, respectively. In contrast, Krm2 shows more 
localized expression in three spots in the pharyngeal region on 
the left and right sides of larvae. Krm4, Krl1 or Krl3 are reported 
to lack clear developmental expression (Zhang and Mao, 2010). 
Cytoplasmic regulators
In the B. floridae genome, a single Dishevelled (Dvl) has been 
identified, and is unusual in being one of the only known Wnt path-
way members to be expressed asymmetrically in the animal pole 
in cleavage stages (Wang et al., 2016). This translates to stronger 
dorsal expression in gastrula stages. Although broadly expressed 
in the mesendoderm of neurula stage embryos, at least in early 
stages there is an apparent antero-posterior gradient. From late 
neurula to early larval stages, Dvl is broadly expressed, but most 
strongly in the paraxial mesoderm forming the somites (Wang et 
al., 2016).
Adenomatous polyposis coli (APC) is a tumour suppressor 
associated with colorectal cancers, and is a key protein of the 
“destruction complex”. Apc expression has been documented in 
B. floridae, where it was found to be ubiquitous in early cleavage 
stages and blastulae (Wang et al., 2016). Particularly in larval 
stages, Apc expression is similar to that of LRP5/6 in concentrat-
ing in anterior neurons of the CNS as well as in the pre-oral pit 
(Wang et al., 2016).
Three kinases associated with b-catenin destruction in the ab-
sence of Wnt/Fz/LRP signalling have been characterized: GSK3b, 
CK1a and CK1δ (Wang et al., 2016). GSK3b gene expression 
in B. floridae is broad, occurring almost ubiquitously from early 
cleavage to larval stages in mesendoderm (Wang et al., 2016). 
CK1a and CK1δ  show similar expression until gastrulation, when 
CK1δ appears to be more strongly expressed dorsally. Asym-
metry in dorsal mesoderm and the neural plate continues for both 
transcripts throughout neurulation, with an absence of expression 
most anteriorly. Expression of CK1a and CK1δ  diverge somewhat 
in late neurulae, with the most distinct patterns found in larvae 
(Wang et al., 2016); expression continues to be absent in anterior 
structures such as the cerebral vesicle, and CK1δ is downregulated 
except in some pharyngeal structures, possibly representing the 
club-shaped gland or endostyle (Wang et al., 2016).
Two Axin proteins have been identified in vertebrates, Axin and 
Axin2/Conductin, both of which may act as scaffolds for the deg-
radation of b-catenin (Chia and Costantini, 2005). The expression 
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of B. floridae Axin has been reported (Beaster-Jones et al., 2008, 
Wang et al., 2016), and is particularly interesting as vertebrate 
Axin2 is not only a negative regulator but also a target of Wnt/b-
catenin signalling (Jho et al., 2002). As for other members of the 
destruction complex, early expression of Axin is broadly uniform 
until after the blastula stage (Wang et al., 2016). In gastrulae, Axin 
is expressed throughout the mesendoderm, but most strongly 
around forming lips of the blastopore excluding the ectoderm 
(Beaster-Jones et al., 2008, Wang et al., 2016). By late gastrula/
early neurula stages however, Axin is strongly expressed in the 
forming posterior growth zone, with no detectable expression in 
the anterior-ventral mesendoderm (Beaster-Jones et al., 2008, 
Wang et al., 2016). In late neurulae and larvae, transcripts are 
detected in the growth zone/forming tailbud (Beaster-Jones et al., 
2008, Wang et al., 2016), consistent with expression of many Wnt 
ligands, as well as possibly in patches in the pharyngeal endoderm 
(Wang et al., 2016). 
Nuclear signalling 
The key effector of Wnt/b-catenin in the nucleus is b-catenin 
itself. b-catenin, known by the name Armadillo due to its mutant 
“naked” cuticle phenotype in Drosophila embryos, consists of an 
intrinsically disordered N-terminal region, a central  Armadillo domain 
consisting of repeating alpha-helix coiled coils, and a C-terminus 
containing the transactivation domain. In vertebrates, 9 Armadillo 
containing proteins within three subfamilies have been identified, 
of which two b-catenin orthologues exist: b-catenin itself, and 
Plakoglobin (g-catenin) (McCrea and Gottardi, 2016). Surprisingly, 
the developmental expression of amphioxus’ unique b-catenin has 
still not been reported. However, the protein has been localized 
using two different antibodies, one in B. floridae (Holland et al., 
2005) and the other in B. belcheri (Oda et al., 2004, Yasui et al., 
2002). The first was generated against the N-terminal 173 amino 
acids of the sea urchin Lytechinus variegatus protein, while the 
second recognises the C-terminus of vertebrate b-catenin (Holland 
et al., 2005, Oda et al., 2004, Yasui et al., 2002). Interestingly, the 
antibodies have together revealed the transcriptional and adhesive 
functions predicted for the protein. In particular, in B. floridae, the 
N-terminal antibody localises to the animal pole in early cleavage 
stages, with clear nuclear localisation in all blastomeres until gas-
trulation. In gastrulae, nuclear b-catenin is most evident around 
the blastopore and then in the ectodermal lips of the neural plate. 
Nuclear localization is lost in the neural plate itself and dorsal 
ectoderm, remaining ventro-posteriorly until late neurula stages 
(Holland et al., 2005). In contrast, the C-terminal antibody clearly 
shows that b-catenin is also found in the membranes (Oda et al., 
2004), where it colocalizes with amphioxus Cadherin-like proteins 
at the adherens junction (Oda et al., 2004), but only localizes to 
nuclei clearly in some early stages (Yasui et al., 2002), and in a 
distribution that differs somewhat from that seen by Holland and 
colleagues (Holland et al., 2005). While the antibody used in B. 
floridae is no longer available, that used in B. belcheri is commer-
cially available and has been used to assess the cellular structure 
in B. lanceolatum adult regenerating tails (Somorjai et al., 2012b). 
Interestingly, b-catenin appears to be upregulated at the membranes 
and adherens junctions in the blastema (Somorjai et al., 2012b), 
similarly to the larval tailbud (Oda et al., 2004), but is also not 
appreciably detectable in the nucleus. This may either reflect the 
very low (non-detectable) levels of b-catenin actually required to 
mediate nuclear signalling at steady states, or a conformational 
change in the protein that might mask the epitope when it shuttles 
into the nucleus. 
b-catenin binds T-cell factor/Lymphoid enhancer-binding factors 
(TCF/LEF) in the nucleus, in addition to a number of other proteins 
including CtBP (C-terminal binding protein), to mediate target gene 
activation or repression in a cell-context specific fashion. In amphi-
oxus, a single Tcf/Lef has been identified; in mammals, four TCF 
genes exist, TCF1 (or TCF7), TCF2 (or LEF1), TCF3 (or TCF7L1) 
and TCF4 (and TCF7L2), which have complex spatio-temporal 
regulation, and which differ in their mode of action. A complete 
developmental expression profile has been characterized in B. 
floridae (Lin et al., 2006). Cytoplasmic maternal Tcf/Lef  localises 
to the animal pole until gastrulation, at which stage zygotic expres-
sion is seen in mesendoderm. Expression is detectable in the 
anterior end of the neural plate and anterior notochord, as well as 
in the pharynx, hindgut, and somites in neurulae. The notochord, 
forming somites and pharynx continue to express Tcf/Lef  in early 
larvae, as well as the tailbud, the ciliated pit, and the cerebral 
vesicle (Lin et al., 2006). Careful mapping in B. lanceolatum at 
the 7 somite neurula stage suggests this region marks the basal 
domain within the rostral and intermediate compartments of a 
hypothalamo-prethalamic primordium (HyPTh), and thus anterior 
to the diencephalon sensu stricto (Albuixech-Crespo et al., 2017).
Groucho acts as co-repressor with TCF/LEF, but is directly dis-
placed by b-catenin upon Wnt/b-catenin pathway activation (Daniels 
and Weis, 2005). Groucho is expressed in B. floridae ubiquitously 
until the blastula/early gastrula, when it is expressed throughout 
tissues except the ectoderm. This becomes more predominant 
on the dorsal side, with an apparent gradient of expression stron-
gest in anterior and dorsal mesendoderm and the neural plate by 
neurula stages. By the late neurula, expression is absent in the 
midline, and more prominent in the posterior growth zone, the 
anterior endoderm, and in the paraxial mesoderm of the somites. 
By larval stages, expression is reported to decrease, remaining 
only near the tailbud and in parts of pharynx (Wang et al., 2016).
Functional studies
Studies of Wnt/b-catenin signalling in cephalochordates have 
predominantly focused on its role in polarity establishment and A/P 
axis formation. The primary means of addressing this in amphi-
oxus, as in many other organisms, has been through the use of 
small molecules that target the GSK3b kinase. Inhibition of GSK3b 
through lithium treatment, the application of BIO, CHIR99021, Al-
sterpaullone or 1-Azakenpaullone result in stabilisation of b-catenin 
protein, which is then free to enter the nucleus where it binds its 
transcriptional targets to activate downstream signalling (Kramer et 
al., 2012). So far, no study has achieved Wnt signalling knockdown 
by directly targeting ligands or receptors during embryogenesis.
The earliest studies of Wnt/b-catenin signalling in amphioxus 
addressed the role of early polarity establishment using lithium 
treatments in B. belcheri (Yasui et al., 2002) and B. floridae (Holland 
et al., 2005). In B. belcheri, treatment after fertilisation results in 
defects in cleavage and the generation of masses of cells lacking 
obvious polarity, with “escapers” developing into radially symmetric 
embryos, but which maintain some dorso-ventral polarity (Yasui 
et al., 2002). Short pulses of lithium starting at the early blastula 
stage in B. floridae generate exogastrulae, but a slight delay in 
treatment permits gastrulation and some elongation to occur to 
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produce truncated but largely recognizable larvae (Holland et al., 
2005). Treatment in both cases results in modified distribution of 
b-catenin to the nucleus (Holland et al., 2005, Yasui et al., 2002), 
and suggests an important conserved role for Wnt/b-catenin in A/P 
polarity establishment in chordates, but not dorsal determination 
as found in vertebrates (Holland et al., 2005, Yasui et al., 2002).
In addition to its role in early polarity establishment, Wnt/b-
catenin signalling plays a number of roles during antero-posterior 
(A/P) axis extension and patterning, possibly in combination with 
other pathways. Holland and colleagues (Holland et al., 2005) 
demonstrated that following the pulse of lithium treatment at the 
late blastula the treated embryos are significantly more elongated 
than controls by mid-neurula stages. Although morphologically 
somewhat amorphous, lithium treatment clearly caused a lack of 
anterior and neural plate identity (Holland et al., 2005). Combin-
ing similar treatments with retinoic acid (RA) or BMS009 (an RA 
antagonist), Onai and colleagues (Onai et al., 2009) show that 
Wnt/b-catenin and RA have differential effects on A/P patterning, 
even though phenotypes may appear similar. As expected, lithium 
caused anterior truncation and posteriorization, with concomitant 
changes in anterior, neural and posterior marker expression, while 
RA treatments often showed more subtle effects, at least until larval 
stages. In contrast, modulating RA results in dramatic changes in 
Hox1 and Hox3 domains of gene expression, while lithium does 
not. Interestingly, treatments of 0.75-1.5 mM with the more specific 
GSK3b inhibitor Alsterpaullone are reported to show similar effects 
to lithium treatment, but with more severe elongation defects (Onai 
et al., 2009). Nevertheless, taken together, the results indicate a 
clear effect of Wnt/b-catenin on determining posterior identity in 
amphioxus, but highlight a parallel function of both Wnt and RA 
signalling in specifying neuronal identity and the hindbrain terri-
tory, respectively. Moreover, the results suggest that there may 
be only limited cross-talk between RA and Wnt/beta-catenin in 
amphioxus, in contrast to the situation in vertebrates (Onai et al., 
2009). Chemical inhibition using two specific GSK3b inhibitors has 
identified possible downstream targets of Wnt/b-catenin signalling 
both during gastrulation and axis extension (Dailey et al., 2017). 
Continuous treatment with 1-Azakenpaullone at 10mM from late 
gastrula onwards results in expansion of the posterior Brachyury2 
(Bra2) domain by mid-neurula, as expected if the latter were a bona 
fide target of Wnt/b-catenin signalling, as well as a lack of anterior 
structures including a pharynx in larvae. This is accompanied by a 
downregulation of Sp5 in the same domain, an unexpected result 
given that Sp5 was shown to be activated downstream of canoni-
cal Wnt/b-catenin signalling (Fujimura et al., 2007, Weidinger et 
al., 2005). The authors propose that this may be the result of a 
negative auto-regulatory feedback loop, as other pharmacological 
treatments result in Sp5 upregulation (Dailey et al., 2017), highlight-
ing the importance of developmental stage and duration of signal 
modulation in evaluating the role of any given signalling pathway.
In one of few studies in which direct targeting of Wnt pathway 
components has been achieved, Onai and colleagues show that 
Dkk3 plays a role in head formation in B. floridae, similarly to 
Dkk1/2/4 members in other systems (Onai et al., 2012). Injection 
of morpholinos (MO) directed against Dkk3 resulted in severe 
truncations by larval stages, with specific loss of anterior structures 
including the head and pharynx, concomitant with a reduction in 
anterior markers. Treatment with 0.5mM of the GSK3b inhibitor 
BIO has similar, albeit stronger effects, particularly in posterioriz-
ing embryos. Evidence that Dkk3 knockdown potentiates the BIO 
phenotype, combined with experiments in Xenopus animal caps, 
suggests that Dkk3 plays dual roles in amphioxus: it can inhibit 
both Wnt/b-catenin and Nodal/Vg1 signalling, although the latter 
is probably not its dominant function and does not appear to be 
mediated through amphioxus Dkk3’s novel TGF-b R2 domain (Onai 
et al., 2012). This study highlights some fundamental differences 
in the roles of signalling pathways in axis specification between 
cephalochordates and vertebrates.
The only other study to functionally address components of 
the Wnt pathway showed that amphioxus sFRP1/2/5 is a likely 
antagonist of a subset of Wnt proteins using Xenopus luciferase 
and secondary axis formation assays (Kong et al., 2012). Knock-
down and overexpression in amphioxus embryos will be crucial 
to validate these results.
Conclusions
Although our knowledge concerning the embryonic functions of 
different signalling pathways in amphioxus is still incomplete, the 
analysis of gene expression patterns and the use of pharmacologi-
cal treatments and other functional techniques already give some 
insights into the evolution of their function in the chordate lineage. 
While some signals seem to play a conserved role with those in 
vertebrates, like RA in antero-posterior patterning, others seem 
to act differently in each chordate clade in the control of several 
developmental processes, such as for FGF during somitogenesis 
or Wnt/b-catenin in dorsal determination. More detailed compari-
sons should help us understand how vertebrates acquired their 
specific morphological traits, and we believe the development of 
new genome editing techniques such as TALEN (Transcription 
Activator-Like Effector Nuclease) or CRISPR-Cas9 (Clustered 
Regularly Interspaced Short Palindromic Repeats-Cas9 nuclease) 
(Chen et al., 2014) will open new avenues to better decipher how 
cells communicate during embryogenesis in amphioxus.
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